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ABSTRACT

STRUCTURAL ANALYSIS OF CYTOKINE SIGNALING MODULATORS

by
Cristina lleana Silvescu
University of New Hampshire, May, 2006

The N-linked glycans attached to cytokine receptors modulate signal
transduction by interacting with galectin-3 and generating a cell surface lattice.
This opposes constitutive endocytosis and reduces the thresholds for cytokine
signaling. The preferred ligands for galectin-3 are the poly-N-acetyl
lactosaminylated tetra-antennary glycans which are synthesized by Mgat 5 and
are present at high levels in tumor cells. A null mutation in Mgat 5 inhibits lattice
formation and cancer progression in cells with an oncogenic background. GlcNAc
feeding reestablishes lattice formation, cytokine signaling and tumorigenesis.
A MALDI-TOF analysis was employed to identify the N-glycans involved in
modulating signal transduction in wild type and null Mgat 5 cells grown with
different GlcNAc supplements. Native N-glycan profiling showed alterations in Nglycosylation generated by GlcNAc supplements through stimulation of
hexosamine pathway. After methylation the tetra-antennary and poly-N-acetyl
lactosaminylated glycans were identified only in Mgat 5 wild type cells either
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supplemented or not with GlcNAc. These structures were absent from the
signaling deficient Mgat 5 null cells. Although lattice formation and tumor
progression are reestablished after GlcNAc feeding, the preferred galectin-3
ligands were absent from Mgat 5 null cells. Collision Induced Dissociation in a
MALDI-IT-TOF instrument was used for N-glycan structural determination. For
monitoring the alterations in N-glycosylation, null and wild type Mgat 5 cells were
grown in medium supplemented with increasing GlcNAc concentrations. The Nglycans were extracted and subjected to neuraminic acid release to facilitate
quantitative estimation. Oligosaccharide profiles for the Mgat 5 wild type cells
showed little variation in the high mannose glycan series and a slight increase in
the relative abundances of complex type glycans. In the Mgat 5 null cells the
increments in GlcNAc concentration determine increasing levels of bi- and triantennary glycans and decreasing levels of high mannose glycans. These
suggest that present in a higher number the glycans with lower LacNAc
multiplicity are able to establish lattice interactions with adequate avidity to
stimulate cytokine signaling and tum or progression in a Mgat 5 null background.
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CHAPTER 1

BACKGROUND AND HYPOTHESIS

The multiple and diverse functions that cells perform during their lifetime
are regulated by the cell’s environment through signal transduction. This
communication system involves an environmental signal, a cellular signal
receptor and an intricate sequence of intracellular biochemical reactions. The
signal is amplified by the enzymatic cascades downstream receptor and
activates specific transcription factors to produce complex metabolic responses
with implications in cell nutrition, respiration, proliferation, differentiation and cell
cycle control.

Herein, I am analyzing the biochemical mechanisms and the

molecular structures which determine the residency time of cytokine receptors at
the cell surface and modulate receptor activation and signal transduction.
Cytokines comprise a diverse group of soluble proteins and peptides,
which act as humoral regulators at nano- to picomolar concentrations and which
modulate the functions of individual cells or tissues. Although they were
characterized primarily as factors involved in activation and proliferation of
immune cells, later studies have shown that they are able to influence growth
and differentiation of a large array of cell types which present a surface receptor.
Different cytokines and growth factors are produced by a wide range of cell types
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and can exert their biological function on targets situated adjacent or remote from
the secretory cell. Although most cytokines have specific receptors and defined
functions they also show redundancy by overlapping their interactions and
generating a network of interdependent pleiotropic effects (Olsson 1993).
Cytokine synthesis is initiated by activation factors or by other cytokines
and is regulated, depending on cell type and developmental age, through gene
expression, alternative mRNA splicing and various posttranslational
modifications. Also, many cytokines balance their own concentration by providing
feedback to the biosynthetic pathways through an autocrine mechanism
(Oppenheim et al. 2000).
Another level of cytokine activity regulation is through expression of their
transmembrane receptors. Ligand availability and the absolute number of
receptors on the cell surface are major limiting factors for signal transduction
(Gurdon and Bourillot 2001). Signaling down-stream of receptor tyrosine kinases
promotes vesicular trafficking and constitutive endocytosis (Nishikawa et al.
1988). Receptor down-regulation through endocytosis is the result of ligandinduced internalization of receptor/ligand complexes and their subsequent
degradation by lysosomes. The internalized receptor molecules can also be
recycled and used for reassembly of new transmembrane receptors (Sorkin and
Waters 1993). By promoting receptor internalization, endocytosis has an
important role in terminating the cytokine influence on the cell surface. An upregulated signal from the cytokine molecules or a mechanism that opposes
constitutive endocytosis could account for the elevated number of cytokine

2
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receptors often encountered at the cell surface in carcinomas.
Although tumor progression can be attributed to multiple factors, sustained
growth signal transduction has a major role in deciding the cell’s fate. Different
cytokines can work in parallel to supply the cell with signals for proliferation. At
the same time, a specific class of cytokines called “cellular survival factors”
generate secondary signals, which prevent apoptosis and act in synergy with the
growth factors to maintain colony propagation (Balkwill 2001). Because of these
effects, many of the genes that encode different segments in the signal
transduction cascade or receptor proteins are considered proto-oncogenes.
Interestingly, most of the cytokines involved in cell proliferation or
differentiation, as well as their receptors, are glycoproteins. During signal
transduction, cytokines that possess lectin domains can enhance multimerization
through interactions with the carbohydrates on another monomer or with
carbohydrate structures on receptors or matrix molecules (Opdenakker et
al. 1995). At the same time, the complex sugars expressed on the extracellular
segment of the cytokine receptors can establish multivalent interactions with cell
surface lectins and generate a local superstructure which maintains signal
transduction across the membrane. The fact that complex-type branched glycans
and cytokine receptors are commonly up-regulated in tumors, which correlates
with poor prognosis (Fernandes et al. 1991; Seelentag etal. 1998), suggests their
role in modulating cell fate through the interactions they establish at the cell
surface.

3
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1.1 The Hexosamine Pathway Supplies the Building Blocks for
N-glycan Biosynthesis

Glucose is the universal nutrient preferred by most organisms as the
primary source of carbon and energy, with fundamental roles in cell growth and
proliferation. This may explain why cells have developed numerous and
sophisticated glucose-sensing mechanisms.
Single celled eukaryotes perceive glucose as a nutrient, but also as an
anabolic signal which binds and activates an array of receptors. These signals
influence cell polarity and migration towards the nutrient, glucose uptake by
activation of membrane transport and glycolysis with production of energy and
cell growth (Kaniak et al. 2004). To modulate cellular morphogenesis and
proliferation, multicellular organisms have developed intricate mechanisms which
rely on a complex network of information received from cooperating or
antagonizing cytokines (Olsson 1993). In this way, the cells’ activities can be
finely tuned to their own needs, but also to the requirements of their systemic
environment. Although glucose remains the preferred nutrient in animals, the
signaling process is dominated by cell-cell contacts and cytokines influences
(Ozcan and Johnston 1999). Glucose availability and its commitment to
glycolysis is required for signaling downstream of anabolic receptor tyrosine
kinases. This provides positive feedback to membrane transporters and
stimulates glucose up-take and glycolysis in cultured mammalian cells (Gottlob et
al. 2001). At the same time, glucose gives positive feedback to cytokine signaling

4
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pathways and maintains receptor activation (Overturf eta l. 1999). This project
identifies the dependency between nutrient availability and regulation of growth
and proliferation signal transduction in tumor cells.
Most mammalian cells have developed membrane transporters
specialized for unique monosaccharides and capable of scavenging the
environment for traces of nutrient (Panneerselvam and Freeze 1996). Although
these transporters can be very efficient, the highest monosaccharide traffic is
attributed to glucose and fructose. Glucose is used in a series of interdependent
metabolic reactions to generate almost any other type of monosaccharide (Figure
1). After phosphorylation by hexokinases and isomerization, monosaccharides
are activated through a reaction of nucleotide transfer. The high-energy donors
generated in this way are ready to be used in glycoconjugate biosynthesis.
Although many monosaccharides are interconvertible by establishing equilibrium
reactions between each other, the biosynthetic pathways can be tightly regulated
by the ratio between the quantities of available monosaccharide and those
needed in construction of various glycoconjugates. The surplus or deficiency of
certain monosaccharides provides feedback to the enzymes that catalyze the
rate-limiting transformations in the pathway. Another control level of
monosaccharide biosynthesis is through the energy-consuming reactions, which
are dependent on glycolysis and the cell’s energy charge. These observations
suggest that nutrient availability influences not only glycolysis, but also
monosaccharide interconversion and synthesis of glycosylated molecules.

5
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Figure 1. Hexosamine pathway and monosaccharide interconversion.
Adapted from Varki eta l. 1999.

Transformation of glucose to glucose-6-phosphate is followed by
isomerization to fructose-6-phosphate until equilibrium is established. These
reactions bring the metabolic pathway to a dichotomy because fructose-6phosphate is the common entry point for both glycolysis and the hexosamine
pathway (Bendiak and Schachter 1987). If phosphofructokinase is activated, the
monosaccharides enter glycolysis to provide the cell with energy. On the other
hand, activation of glutamine-fructose-6-phosphate aminotransferase (GFAT)
leads to de novo biosynthesis of uridine diphosphate N-acetylglucosamine (UDP-
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GlcNAc) through the hexosamine pathway. The reactions catalyzed by these two
enzymes are unidirectional and commit the substrate to irreversibly follow one
pathway or the other.
Interestingly, overexpression of GFAT in skeletal muscle of transgenic
mice results in severe insulin resistance (Hebert et al. 1996). Also, shunting the
reaction catalyzed by GFAT through infusion of glucosamine directly activates
the hexosamine pathway and generates insulin resistance in skeletal muscle of
normal rats (Giaccari 1995; Rossetti eta l. 1995). Insulin resistance is a cell
saturation signal, which implies that the hexosamine pathway plays the role of a
nutrient sensor. This suggests that the two competing pathways, hexosamine
synthesis and glycolysis, have important roles in maintaining metabolic
homeostasis by integrating information received from anabolic receptors.

1.2 UDP-GlcNAc Is Rate Limiting for Branching of Complex-type
N-linked Glycans

The primary effect of hexosamine pathway stimulation by nutrient
availability is an increase in the intracellular concentration of Nacetylglucosamine (GlcNAc) which is followed by transformation to UDP-GlcNAc.
This is a high-energy molecule which can be used for generating other Nacetylhexosamines (HexNAc) or for biosynthesis of various glycoconjugates
(Figure 1). N-linked glycosylation is one of the major metabolic pathways that use
UDP-GlcNAc for synthesis of a large repertoire of structurally diverse asparagine

7
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(N) - linked glycans.
N-linked glycosylation is a co-translational modification of nascent proteins
which takes place in the lumen of the rough endoplasmic reticulum (ER). This
process is regulated contextually, depending on the cells’ developmental stage
and the specific functions performed during that time. Because of this, Nglycosylation shows micro-heterogeneity, which means that proteins with
identical amino acid sequence can have different glycosylation sites occupied
and that each occupied consensus site can carry different glycan structures
(Matthijs eta l. 1998). Although glycosylation defects provide insight into its
physiological functions, at times these are difficult to understand due to their
pleiotropic effects or their various degrees of penetrance, imposed by micro
heterogeneity.
N-linked glycosylation plays important roles in different physiological
aspects like cell adhesion and mobility, cell-cell interactions, cell differentiation or
proliferation, signal transduction and tissue morphogenesis. All these processes
have major implications in deciding the cell’s fate during embryogenesis (Armant
eta l. 1986; Campbell e ta l. 1995), ontogeny (Cremer eta l. 1994) or tissue
regeneration after injuries. Alteration of N-linked glycosylation leads to aberrant
signal transduction, loss of cell cycle control, cell proliferation, tumor progression
and metastasis, impaired differentiation and development.
Moreover, N-glycosylation modulates the immune system through the
interactions established between the host and parasite. Antigen - antibody
coupling, self vs. foreign recognition, leukocyte proliferation (Tulp etal. 1986) and

8
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migration into infected tissues (Hanasaki etal. 1994) and cytokine signaling
through lectin-ligand interactions are all processes mediated by N-linked glycans
or other glycoconjugates.
N-linked glycan biosynthesis starts in the cytosol by activation of GlcNAc1-phosphotransferase, which adds one UDP-GlcNAc molecule to dolichol
phosphate lipid inserted in the endoplasmic reticulum membrane (Figure 2). This
is followed quickly by addition of a GlcNAc molecule and five mannose residues,
in a sequential and linkage specific manner. At this point the dolichol
phosphate/oligosaccharide complex flips from the external ER membrane side to
the internal side and becomes available to the lumenal enzymes. (Rosner et al.
1982).

GlcNAc2Man9Glc3

P
Do)

■

GlcNAc

#

Han

A

Glc

?
i

UOPid

P

I

UON

Del

-► flip ■
Cytosol

Lumen of §R

Figure 2. Biosynthesis of lipid linked glycans.
Adapted from Varki et al. 1999.
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The biosynthesis continues with sequential attachment of four additional
mannoses to the growing lipid-linked oligosaccharides, followed by transfer of
three glucose residues. Production of the final lipid-linked oligosaccharide
GlcNAc2Man 9 GIC3 , as well as the intermediates, is a highly conserved process in
eukaryotes and some prokaryotes (Trombetta 2003) and it serves as the
precursor for N-linked glycan synthesis.
During or after translation, certain proteins enter into the ER for further
processing. The GlcNAc 2 MangGIC3 moiety is transferred en block by the
oligosaccharyltransferase complex from the dolichol-phosphate to the nascent
proteins and facilitates correct folding of glycoproteins (Hammond eta l. 1994).
The glycans are linked to proteins by the asparagine acceptor in a minimal
required sequence of Asn-Xaa-Thr/Ser, where Xaa can be any amino acid
except for proline (N-X-T/S sites).
Attachment of oligosaccharides to polypeptides is essential in eukaryotes.
Although some glycoproteins are functional when their N-glycans are removed
enzymatically or by site-directed mutagenesis, total absence of N-glycosylation is
lethal, as shown by mutant cells or by cells treated with tunicamycin, an Nglycosylationinhibitor (Elbein 1987; Kukuruzinska e ta l. 1987).
Once attached to proteins, N-linked glycans undergo a reverse processing
facilitated by a series of glycosidases residing in ER and Golgi. During
glycoprotein folding, the three terminal glucose residues are released
sequentially. This allows mannosidases to remove the unsubstituted mannose
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monomers in a stepwise fashion and to generate a series of high-mannose type
glycans.
If the chains are trimmed down to only three or five mannose residues, the
oligosaccharides serve as substrates for N-acetylglucosaminyl (GlcNAc)
transferases. These Golgi-located enzymes use the UDP-GlcNAc donors,
provided by hexosamine pathway, to generate hybrid and complex-type N-linked
glycans.
Interestingly, the quantity of UDP-GlcNAc produced and transported to
Golgi is rate limiting for GlcNAc transferases and implicitly for synthesis of
complex-type N-glycans (Oguri et al. 1997; Van den Eijnden et al 1988). The
large quantity of nutrient required and absorbed by anabolic cells activates
glycolysis, which supplies the cell with energy and also stimulates the
hexosamine pathway, which produces UDP-GlcNAc. These observations
suggest that active anabolic cells generate a larger pool of complex type glycans
than other kinds of functional cells and explain, in part, context-dependent glycan
microheterogeneity.
At the same time, tissue cultures set with low glucose concentrations in
the growth medium reduce the efficiency of epidermal growth factor receptor
(EGFR) substitution by the dolichol-phosphate oligosaccharyltransferase
complex (Konishi and Berk 2003). Severe nutrient shortage inhibits cell growth
and proliferation and also impairs substitution of N-X-T/S sites.
A bioinformatics study performed by our collaborators shows that cytokine
receptors which stimulate cell proliferation, growth and oncogenesis have longer
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extracellular domains and higher incidence of glycosylation sites than the
receptors involved in morphogenesis (Lau et al. in prep.). These findings suggest
that signal transduction can be modulated in proliferative cells through
expression on the surface of a larger or more diverse population of complex-type
N-glycans generated by activation of the hexosamine pathway and nutrient
availability.

1.3 Complex-type N-linked Glycan Diversification
by GlcNAc Transferases

N-linked glycan processing in the Golgi is controlled by genetic, epigenetic
and environmental factors. The structural variability of complex-type glycans
depends on cell-specific regulation of glycosyltransferase genes, concentration of
monosaccharide donors and competition between enzymes for acceptor
intermediates as well as the stereochemical environment created by the protein
sequence around the glycosylation site (Dennis et al. 1999).
As the glycoproteins pass through the Golgi compartments, the attached
oligosaccharides undergo remodeling by different families of
glycosyltransferases. GlcNAc transferases (Tl-Ti; Figure 3) perform their
biological activities in medial and trans Golgi and generate a pool of complextype glycans with various contents of GlcNAc residues. At the same time, this
class of enzymes is responsible for branching the N-linked glycans and
producing precursors for bi-, tri-, tetra-, and penta-antennary structures.
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Figure 3. Golgi N-linked glycan processing. Adapted from Dennis eta l. 1999.

GlcNAc transferase I (GnTI or Tl) adds the first GlcNAc residue to the
three or five mannose core in the position p-1,2 of the mannose residue linked in
a-1,3 to the middle mannose (Figure 4). This derivatization is required for
subsequent modifications by other transferases. In the animal kingdom GnTI
function has proven to be essential for organogenesis because complete
absence of its products, generated by gene knockout, is lethal in embryos (Ioffe
and Stanley 1994; Metzler eta l. 1994).

udH B

Figure 4. N-glycan branching by GlcNAc transferases.
Adapted from Varki et al. 1999.

GnTII (Til) adds the second GlcNAc residue to the tri-mannosyl core in the
position p-1,2 of the a -1 ,6 mannose (Figure 4) and generates the precursor to
biantennary structures. GnTII processing is required for branching of complex Nglycans by other transferases. Although GnTII mutant embryos survive, the
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impairment of the enzyme activity often becomes lethal after birth due to multiple
organ and system failures (Jaeken et al. 1994; Chui et al. 1997).
Activation of either GnTIV or GnTV produces precursors to the
triantennary structures by addition of GlcNAc residues to the core a 1-3 mannose
and a 1-6 mannose, respectively. Although the two enzymes compete for the
same substrate, derivatization by GnTV requires GnTII activity and facilitates
GnTIV branching. N-glycan processing through activation of both enzymes
produces oligosaccharides with four GlcNAc residues, which can be substituted
further by galactosyltransferases and sialyltransferases to generate mature tetraantennary structures (Figure 3).
GlcNAc transferase activities initiate N-glycan diversification by providing
substrates for other glycosyltransferases, which generate a plethora of partially
or fully decorated oligosaccharides. This extensive structural variability allows
glycoproteins to establish multistep interactions with a wide range of lectins
situated mostly on the cell surface. The activity of glycosyltransferases takes
place in Golgi, an organelle dedicated to production of cell surface and secreted
structures and generates the lectin ligands.
Although abolition of the initial steps of Golgi N-glycan remodeling is
lethal, null mutations in the genes overseeing later reactions in the pathway
generate less severe phenotypes. In Caenorhabditis elegans ablation of the gly-2
gene, which is a homologue of the GnTV gene in mice, is without visible defects
despite resulting in an enzymatically null phenotype (Warren et al. 2002). These
observations suggest that the upstream and more conserved parts of the N-
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glycan remodeling pathway have well rooted implications in modulating cell fate
during morphogenesis and development, while the newly evolved structures
have roles in finely regulating ultrasensitive interaction in a systemic
organization.

1.4 Roles of Moat 5 in Signal Transduction and
Cancer Progression

GnTV or UDP-N-acetylglucosamine: a-1 , 6 mannoside (3-1, 6 Nacetylglucosaminyl transferase is encoded by the Mgat 5 gene in mammals. This
enzyme adds a GlcNAc residue in the (3-1, 6 position to the a-1 , 6 core mannose
and generates half of the tri-antennary glycan pool and all tetra-antennary
glycans. Mgat 5-modified glycans are preferred substrates for initiation of poly-Nacetyl-lactosaminylation (Cummings and Kornfeld 1984). Although the tetraantennary structure is not required for addition of LacNAc or [Gal(31-4GlcNAc(313] extensions, the presence of the core p-1 , 6 GlcNAc linkage enhances synthesis
of poly-LacNAc termini (Yamashita et al. 1984; Pierce and Arango 1986). The
length of the polylactosamine extension is influenced by the availability of
activated monosaccharides, the concentration of transferase p-1,3 GlcNAc-T(i)
and also by the competition among chain terminating enzymes like
sialyltransferases or fucosyltransferase. The [G aipi-4G lcN A cpi-3] unit can be
repeated between

2

and

1 0

times and it can be attached to all of the branches.
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This generates another level of variability among the N-linked glycan structures
and facilitates interaction with lectins with different affinities.
Galectins are a family of soluble lectins that bind p-galactosides, but with
relatively low affinities. However, the binding affinities increase depending on the
stereochemical environment of p-galactosides, especially if this residue is linked
into a lactose or LacNAc sequence (Leffler and Barondes 1986). Galectin
affinities for N-glycans are proportional to GlcNAc-branching and the number of
N-acetyllactosamine units (Hirabayashi et al. 2002). Being the preferred
substrate for poly-N-acetyllactosaminylation, the tetra-antennary glycans
synthesized by Mgat 5 provide the highest affinity ligands for galectins.
The only antiapoptotic member of the glectin family (Kim at al. 1999),
galectin-3 (Gal-3) binds with high affinity to the [G aipi-4G lcN A cpi-3] unit through
its carbohydrate recognition domain. At the same time, the non-lectin domain of
galectin-3 mediates pentamer formation in the presence of multivalent ligands,
thereby cross-linking glycoproteins in proportion to ligand concentrations (Ahmad
et al. 2003).
Cytokine receptors presenting Mgat 5 modified N-glycans with poly-Nacetyllactosamine extensions interact with galectin-3 and form a molecular
superstructure at the cell surface. The resulting lattice of multimeric galectins and
receptor glycoproteins opposes constitutive endocytosis. In this way the
molecular lattice reduces the thresholds for cytokine mediated signaling by
increasing the time of receptor residency at the cell surface (Partridge et al.
2004). The number and types of N-glycans attached to the receptor extra-cellular
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domain determines the lattice strength and has a proportional impact on cytokine
signaling.
Culturing tumor cells expressing Mgat 5 in the presence of lactose, a
competitor for N-linked glycans in binding galectin-3, reduces receptor
responsiveness to EGF. Treatment with sucrose, a disaccharide similar to
lactose but without galectin-3 ligand properties, had no effect on receptor
activation (Partridge et al. 2004). This comparison shows that signal transduction
is modulated by the lattice through the N-linked glycans attached to cytokine
receptors and not by other possible Mgat 5 modified structures with different
cellular localizations.
Mgat 5 expression as well as branched complex glycans are commonly
up-regulated in cancer and are required for growth signal transduction, epithelialmesenchymal transition, cell motility and metastasis. Moreover, Mgat 5
expression correlates well with poor prognosis (Fernandes et al. 1991; Seelentag.
et al. 1998; Granovsky et al. 2000).
Tumors induced in transgenic mice by polyomavirus middle T oncogene
(PyMT) are generated by activation of Src, phosphatidylinositol 3-kinase and Ras
pathways and are dependent on cytokine receptor stimulation (Webster et al.
1998). Interestingly, the Mgat 5 null mutation (Mga 5'A) is able to decrease
receptor sensitivity to cytokines and to suppress oncogenic progression in
mammary epithelial tumor cell lines isolated from PyMT transgenic mice
(Partridge et al. 2004; Granovsky et al. 2000). Measurements of phosphorylation
and nuclear translocation of extracellular signal regulated kinase (Erk) and Sma
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and Mad protein (Smad) transcription factors show a 100-fold decrease of
receptor sensitivity to epidermal growth factor (EGF), platelet-derived growth
factor (PDGF), insulin growth factor (IGF-1) and fibroblast growth factor (FGF)
and only a 3-fold decrease of receptor sensitivity to transforming growth factor (3
(TGF-p), respectively (Partridge et al. 2004). The glycoprotein-galectin lattice is
deficient in Mga5'/_ tumor cells, which determines an increased rate of receptor
removal from the cell surface. Receptor down-regulation through endocytosis is
inversely proportional to the strength of the lattice, which is generated by the
number of occupied glycosylation sites per receptor and the proportion of poly-Nacetyl lactosaminylated sugars. The difference in receptor sensitivity to EGF
versus TGF-p is determined by the presence of 10 to 12 potentially occupied
glycosylation sites on the EGF receptor (Stroop et al. 2000) and only 1 and 3
sites for the two TGF-p receptors.
Transfection of Mga 5_/" tumor cells with a retroviral vector carrying the wild
type copy of the Mga 5 gene rescues the PyMT oncogenic phenotype and
increases signal transduction, suppresses contact inhibition, increases cell
motility and metastasis (Partridge et al. 2004). These observations reinforce the
role of tetra-antennary and poly-N-acetyllactosaminylated oligosaccharides,
synthesized by the glycosylation pathway downstream of Mgat 5, in modulating
carcinogenesis through the cell surface multimeric lattice.
Remarkably, GlcNAc supplement to the growth media of Mga 57' tumor
cells reestablishes receptor sensitivity to cytokines and increases cell surface
galectin-3 to levels comparable to the ones in Mga 5+/+ (Lau et al. in prep.).
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These results suggest that the increased concentrations of absorbed GlcNAc are
able to rescue the formation of the receptor glycoprotein-galectin lattice in the
absence of Mgat 5 function.
Glutamine-fructose- 6 -phosphate aminotransferase (GFAT) is the key
regulation point of the hexosamine pathway and its activity is tightly controlled
through feedback from its product concentration (Sayeski and Kudlow 1996). In
Mga5_/'tu m o r cells GlcNAc supplement bypasses this control point and is able to
activate the hexosamine pathway in a low glucose background. Hexosamine
pathway excitation generates UDP-GlcNAc, which is used in biosynthesis of
various glycoconjugates, among which are the N-linked glycans attached to the
extracellular domain of the cytokine receptors.
This project makes an effort to identify the mechanisms by which
environmental factors, like nutrient availability or presence of metabolism
intermediates, are able to provide temporal adaptations in culture cells. I want to
identify the glycan structures produced under Mgat 5 expression and the poly Nacetyl lactosaminylated structures generated by subsequent substitutions.
This is of interest because expression of the Mgat 5 gene is involved in
regulation of different physiological processes by generating N-glycan ligands for
a variety of functional lectins. Interactions established between galectin 3 and the
Mgat 5 modified N-glycans on the T cell receptor (TCR) prevent autoimmune
disease by raising the threshold for T cell activation and limiting TCR clustering
(Demetriou et al. 2001). Also, in epithelial cancer cells, the presence of Mgat 5
modified glycans facilitates epithelial-mesenchymal transition with loss of
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adhesion junctions, reduced contact inhibition and increased cell motility. The
highly motile phenotype shown by metastatic cells is characteristic of active
leukocytes as well. A null mutation in Mgat 5 suppresses the inflammatory
process and inhibits leukocyte extravasation (Partridge et al. 2004).
In our model the Mgat 5 modified glycans increase receptor residency at
the cell surface by participating in formation of the glycoprotein - galectin lattice.
This stimulates signal transduction and activates Ras, PI 3 kinase and Smad 2
and Smad 3 (Oft et al. 2002). In turn, the Ras-Raf-Ets pathway supplies positive
feedback to Mgat 5 expression (Chen et al. 1998).
At the same time, the hexosamine pathway, stimulated by environmental
factors, has major roles in maintaining metabolic homeostasis of N-glycosylation
by supplying donor molecules for N-glycan biosynthesis. GlcNAc supplements to
cell growth media reestablish signal transduction in the Mgat 5 null background.
These findings suggest that both the Mgat 5 modified glycans with polyLacNAc substitutions and stimulation of the hexosamine pathway are able to
generate the cell surface lattice, independent of each other. The objectives of this
project are first, to identify the glycan structures involved in formation of cell
surface lattice in Mga5+/+ cells and the alterations in N-glycan remodeling
produced by GnTV deficit in Mga5'/_background. Second, to identify the
modifications of the hexosamine pathway produced by GlcNAc supplements and
the effects of these modifications on N-linked glycan biosynthesis. Third, to
characterize the glycan structures involved in rescuing the glycoprotein - galectin
interactions in the Mga 5'/_cells supplemented with GlcNAc.
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CHAPTER 2

EXPERIMENTAL APPROACH

2.1 Propagation of Mgat 5 Tumor Cells

Mammary tum or cell lines were established from spontaneous carcinomas
in polyoma middle T (PyMT) transgenic mice on a 129sv x FVB background with
either Mgat 5+/+or Mgat 5_/'genotypes as previously described (Granovsky et al.
2000). Cell lines Mgat 5+/+ (2.6) or Mgat 5'/_(2.9) were generated from mammary
tumors removed from littermate PyMT transgenic mice.
To supplement the hexosamine pathway with UDP-GlcNAc, cells were
grown in glucose-free DME medium (Gibco) supplemented with 0.9 mM DGlucose and 50 mM GlcNAc (Sigma) with 10% serum for 48 hours. To titrate the
effects of GlcNAc, the cells were grown in glucose-free DME media enriched with
0.9 mM D-Glucose and defined GlcNAc supplements. The GlcNAc
concentrations in the titration series were: 0 mM, 12.5 mM, 18.75 mM, 25 mM,
31.25 mM, 37.5 mM, 43.75 mM and 50 mM.
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2.2 Protein Isolation and Purification

The cells were lysed from frozen with a membrane disruption buffer
containing

8

M urea, 2 M thiourea, 4% CHAPS, 65 mM dithiothreitol (DTT), 10

mM acrylamide, 40 mM Tris-HCI pH = 8 and mammalian protease inhibitor cocktail
(Sigma, St. Louis, MO). After 5 cycles of 3 min. each of sonication on ice, the
proteins were quantified with the Bradford Assay (Pierce, Rockford, IL) using the
photometer mode of a UV-Viz. Spectrophotometer (Shimadzu Corporation,
Kyoto, Japan).
Total cell lysate proteins were purified by 3 cycles of dialysis: for 2 hours
in 20 mM NH 4 HCO 3 , 0.05% SDS; followed by over night dialysis at 4°C, in 10
mM NH 4 HCO 3 , 0.02% SDS and then for 2 hours in 5 mM NH 4 HCO 3 . The dialysis
cassettes (Pierce, Rockford, IL) with 7000 MWCO membranes were rehydrated
before using. The purified proteins were lyophilized (Freezone 2.5, Labconco,
Kansas City, MO) and resuspended in water. For comparative analyses equal
quantities of proteins (0.5 mg) were prepared for each cell type and each GlcNAc
treatment.

2.3 N-linked Glycan Release

The proteins were denaturated by heating at 100°C for 15 minutes in 0.05
ml 1X denaturing buffer (5% SDS and 10% /?-mercaptoethanol). The samples
were cooled to room temperature followed by addition of 1/10 volume of 10X G7

23

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

buffer (0.5 M sodium phosphate, pH 7.5) and 1/10 volume of 10% NP-40. The
deglycosylation was performed by proteins incubation with 0.05 U of glycerol-free
Peptide: N-Glycosidase F (PNGase F; NEB, Beverly, MA) for 48 hours at 37°C.

2.4 Protein and N-linked Glycan Separation

The proteins and detergents from the deglycosylation mixture were
extracted using a previously described method (Reinhold and Reinhold 1999)
with some modifications.
The samples were diluted in 5% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic
acid and passed through C18 SEP-PAK® cartridges (Waters) under gravitational
pressure. The columns were conditioned in advance with three washings of four
ml each of the following aqueous solutions:

1

) 80% (v/v) acetonitrile,

0

. 1 % (v/v)

trifluoroacetic acid; 2) 50% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid; 3) 5%
(v/v) acetonitrile, 0.1 % (v/v) trifluoroacetic acid. After loading the samples the
flow through was collected immediately for retrieving the glycans. The cartridge
was washed with 3 ml of 5% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid
solution and the eluant volumes were pooled together. The oligosaccharide
solutions were evaporated to complete dryness in a SpeedVac® Concentrator
(Savant Instruments, Holbrook, NY).
The proteins were recovered from the C18 cartridge by elution with 50%
(v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid. The highly hydrophobic proteins
were eluted with 80% (v/v) acetonitrile,

0

. 1 % (v/v) trifluoroacetic acid.
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2.5 N-linked Glycan Purification

The N-linked glycans were further purified and desalted using Porous
Graphitized Carbon (PGC) columns as described previously (Packer et al. 1998)
with modifications.
The powder PGC column bed was washed three times by vortexing in a
capped tube with four ml of each of the following aqueous solutions:

1

) water;

2

)

1 M NaOH; 3) water; 4) 80% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid; 5)
25% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid;

6

) 25% (v/v) acetonitrile; 7)

water. After each wash the tube was centrifuged and the supernatant was
removed. The cleaned PGC was packed in a 10 pi pipette tip with an
incorporated C18 bed, ZipTip® (Milipore, Danvers, MA). The ZipTip® was fitted to
a 1 ml syringe and the mixed column bed was washed with 25% (v/v) acetonitrile
solution if the sample contained only neutral glycans or with 25% (v/v)
acetonitrile,

0

. 1 % (v/v) trifluoroacetic acid solution if acidic glycans were

expected to be present in the sample. For an unknown glycan mixture the
column was washed with 25% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid
solution. The micro-column was equilibrated with water and the glycan sample,
resuspended in water, was passed through the column with a flow rate of

0 .2

ml/minute. The flow through was collected and reloaded into the column. The
column was washed with water and the flow through was discarded. Neutral
glycans were eluted with 25% (v/v) acetonitrile solution, while acidic glycans
were eluted with 25% (v/v) acetonitrile, 0.1% (v/v) trifluoroacetic acid solution.

25

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

When separation was not desired the glycans were eluted in batch with 25% (v/v)
acetonitrile, 0.1% (v/v) trifluor acetic acid solution. The glycan mixtures were
frozen immediately after elution and lyophilized.

2.6 Oligosaccharide Reduction

Fresh NaBH 4 solution was prepared by adding 10 mg/ml NaBH 4 in an
aqueous solution of 0.01 N NaOH with a final pH between 10 and 12. Dried
oligosaccharides were resuspended in the NaBH 4 / NaOH solution, covered with
a loose cap and incubated at room temperature for 16 hours. The glycan solution
was chilled to 4°C and neutralized with drop-wise addition of 20% acetic acid.
After dilution in 2 ml of ethanol, the solution was dried using a nitrogen
evaporator N-EVAP™ 112 (Organomation Associates, Berlin, MA).
The excess borate was eliminated by successive evaporations with 2 ml of
each of the following solutions:

1

) three times with

1

% acetic acid in methanol;

2

)

toluene; 3) two times with 1% acetic acid in methanol; 4) toluene.
After resuspension in water, the oligosaccharides were desalted by
passing through a column packed with the protonated form of DOWEX AG 50W
X8-400 cation-exchange resin (Sigma-Aldrich, St. Louis, MO). The resin was
conditioned in advance by washing it with an aqueous solution of

2 0

% acetic acid

followed by successive water washes. The eluant was collected immediately
after loading the oligossacharide mixture and was evaporated to dryness in the
SpeedVac®.
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2.7 Oligosaccharide Methvlation

Glycan methylation was performed under controlled conditions of humidity
following a previously described method (Ciucanu and Kerek 1984; Ciucanu and
Costello 2003).
The reduced glycan samples were dried in the SpeedVac® and stored
under vacuum atmosphere in a desiccator with P2 0 5 over night. The dry glycan
samples were re-suspended in 0.2 mL of dimethyl sulfoxide (DMSO; SigmaAldrich, St. Louis, MO) and 1% water. About 0.08 to 0.1 g of NaOH powder was
added to the samples which were flushed with argon, capped tightly, covered
with parafilm and vortexed for 30 minutes. The powdered NaOH was prepared in
advance by grinding the pellets in a mortar and baking the powder at 130°C for 5
hours.
For glycan methylation 0.05 mL of iodomethane (Sigma-Aldrich, St. Louis,
MO) was added to the samples, which were then flushed with argon, capped
tightly, covered with parafilm and vortexed for about 45 minutes. After adding the
iodomethane, the samples were light protected by wrapping the tubes in
aluminium foil. The reaction mixture was diluted with 1mL dichloromethane
(HPLC grade; EMD-Biosciences, San Diego, CA) and stopped by adding, on ice,
1 mL of 10% acetic acid, aqueous solution. The methylated glycans were
extracted in the organic phase and purified by repeated washes with water. After
the last water wash, the samples were frozen and the liquid organic phase was
transferred to a clean tube and dried in a SpeedVac®. The methylated glycans
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were resuspended in methanol (HPLC grade) and were ready for mass
spectrometry analysis.

2.8 Neuraminic Acid Release

Mild acidic hydrolysis was employed for non-specific release of neuraminic
acid residues. Through this chemical approach neuraminic acid and all its
analogs were hydrolyzed independent of the type of glycosidic linkage.
The native, reduced glycans from each cell type and GlcNAc treatment
were dissolved in 0.5 mL of 2 M acetic acid aqueous solution (EMD-Biosciences,
San Diego, CA) and heated at 80°C for 2 hours. The acetic acid was removed by
evaporation. The glycan mixture was suspended in methanol (HPLC grade) and
evaporated again. For mass spectrometry analysis, the methylated
oligosaccharides were resuspended in methanol (HPLC grade).

2.9 MALDI-TOF Mass Spectrometry

The MALDI-TOF glycan profiles were generated using an Axima Curved
Field Reflectron (CFR) mass spectrometer (Kratos-Shimadzu Analytical,
Manchester, UK) equipped with a nitrogen laser, which emits in the ultraviolet
range {A =337 nm). The instrument was externally calibrated, for the reflectron
mode, using a mixture of peptides and protein standards (bradykinin fragment,
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P h R synthetic peptide, ACTH fragment, insulin) covering a mass unit range
between m/z 700 and 6000.
For each analysis, 0.8 jjL of glycan solution was spotted and mixed with
0.8 fjL of matrix on a stainless steel target plate and allowed to dry. Before
analysis the sample spots were resuspended in 0.5-yt/L ethanol and dried again.
All spectra were recorded in reflectron positive-ion mode using as matrix
2,5-dihydroxy benzoic acid (DHB, 10 mg/mL in 50% acetonitrile). The samples
were ablated with 60% of the maximum laser power by rastering over the target
surface. Mass spectra were acquired by averaging 500 profiles generated by 5
laser shots per profile with the post extraction parameter optimized for native
glycans around m/z 3000 and for methylated ones around m/z 4500. Spectra
processing was performed with Kratos Launchpad software.

2.10 MALDI-IT-TOF Mass Spectrometry

MALDI-IT-TOF tandem mass spectrometry was performed on the
Axima QIT instrument (Kratos-Shimadzu Analytical, Manchester, UK). The
instrument was calibrated externally with fullerite in “Mid Mass” mode and with
insulin B in the “High Mass” mode. The ion trap was calibrated on a “dirt
background” sample for a mass range from m/z 400 to 5000. The samples were
spotted on the target plate as previously described. The samples were ionized
with 30-40% of the maximum laser power while rastering on the plate surface.
The number of profiles accumulated was adjusted as a function of the signal
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intensity and some extended to 7000 profiles per spectrum. The fragmentation
patterns in MSn experiments were generated by collision-induced dissociation
(CID) with argon gas. The collision energy in the ion trap was adjusted to
facilitate enrichment of the ion desired to be fragmented further in the MS n +1 step.
Spectra processing was performed with Kratos Launchpad software.

2.11 Peak Annotation

Peak annotation was performed initially by using the program GlycoMod
Tool, a package under the ExPASy (Expert Protein Analysis System) proteomics
server of the Swiss Institute of Bioinformatics (SIB). GlycoMod
(http://ca.expasy.org/tools/glycomod/) is a computer algorithm which generates a
list of possible oligosaccharide compositions depending on parameters inputted
by the user. Also, GlycoMod lists all the hits to GlycoSuite Data Base, which
encompasses most of the naturally occurring glycan structures reported in the
literature.
For peak annotation the GlycoMod hits to GlycoSuite DB were considered
preferentially. To support peak annotations and to resolve between multiple hits
to GlycoSuite DB, various oligosaccharides were subjected to structural analysis
by molecular disassembly.
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CHAPTER 3

NATIVE N-GLYCAN PROFILING

The types of interactions that N-linked glycans establish with different
classes of lectins define them as modulators of various cellular processes under
physiologic or disease conditions. To characterize the N-linked glycans involved
in tumor progression, PyMT mammary tumor cell lines were analyzed in an Mgat
5+/+or Mgat 5_/'genetic background. A mass spectrometry analysis of Mgat 5+/+
or Mgat 5'/_cell lines would identify the GnTV modified oligosaccharides and their
poly N-acetyl-lactosaminylated analogs. These structures establish the
glycoprotein - galectin lattice on the cell surface and lower the threshold for
cytokine signaling. It would be expected that the tetra-antennary and the poly-Nacetyl-lactosaminylated sugars be absent from the lattice-deficient Mgat 5'/_cells.
The alterations in glycosylation pathway were monitored for each genetic
background, in cells grown in a medium with either low glucose or low glucose
supplemented with GlcNAc. This comparative analysis seeks identification of
changes in the hexosamine pathway reflected in the N-glycan biosynthesis. We
hypothesized that absence of GnTV function in the Mgat 5'1' cell line inhibits
synthesis of tetra-antennary glycans and lattice formation. At the same time,
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stimulating the hexosamine pathway with GlcNAc supplements will create a
build-up of the glycans upstream of GnTV and increase synthesis of tri-antennary
and bi-antenary poly-N-acetyl-lactosaminylated structures. The N-linked glycans
were released from total cell proteins, purified and submitted to mass
spectrometry analysis.

3.1 Comparative Analysis of Native N-linked Glycans

Mass spectrometry analysis of oligosaccharides released from biological
samples may prove to be challenging due to the low concentration of analyte
encountered in the complex mixture of molecules extracted from the total cell
lysate. In this case two different methods were employed to release
oligosaccharides attached to glycoproteins.
Hydrazinolysis is a non-specific method for releasing N-linked and Olinked glycans (Patel et al. 1993). This chemical release method is advantageous
in profiling all types of glycans and especially the ones that are attached to
proteins in a stereochemically enclosed glycosylation site. The method’s major
disadvantage is that, when a small quantity of glycoprotein is subjected to
hydrazinolysis, the reaction generates high background levels, which makes it
difficult to identify the low concentration molecules in a sample mixture (results
not shown). For this reason the glycans were released using peptide Nglycosidase F (PNGase F), an enzyme that specifically cleaves N-linked glycans
(Maley et al. 1989). PNGase F hydrolyzes the linkage between the chitobiose
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unit and the peptide to yield the complete sugar moiety and a sugar-free peptide
in which asparagine is converted to aspartic acid (Mort and Pierce 1995). This
enzyme is extremely versatile and all commonly encountered N-linked sugars are
susceptible to this enzyme except those occurring on C- or N-terminal
asparagines. Also, the glycan substitution in the position a1-3 of the reducing
end GlcNAc hinders the enzyme’s access to the glycosylation site and renders
the oligossaccharide resistant to enzymatic treatment (Tretter et al. 1991).
Mass spectrometric profiling of released native N-glycans using MALDITOF in the positive ion mode is an initial step for identifying oligosaccharides
without derivatization. Both neutral and basic glycans can be detected using this
method, because these oligosaccharides ionize by forming positively charged
Na+ adducts. The acidic glycans ionize by losing one proton from each carboxylic
group and forming negatively charged species, which cannot be detected in
positive ion mode.
A comparative analysis of the Mgat 5+/+ and Mgat 5'/_cells and those
supplemented with GlcNAc provide the native N-linked oligosaccharides profiles
in the figures below. The resultant spectra show the series of high mannose
glycans generated by mannosidases located in ER and cis-Golgi. The peaks
corresponding to high mannose sugars were marked in all of the spectra with a
dot. The complex and hybrid glycans show variations in relative abundance for
the different GlcNAc treatments.
The Mgat 5+/+ cell line grown in low glucose media presents a profile with
series of concentrated high mannose glycans and less abundant complex and
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hybrid sugars (Figure 5). The succession of reactions in the glycosylation
pathway can be followed in the spectrum starting from the Man9GlcNAc2
structure (m/z 1907.6) and going along the reverse processing of high mannose
glycans series, with decrease in molecular weight, down to Man5GlcNAc2 (m/z
1081.7) or Man3GlcNAc2 (m/z 935.7). These two structures are substrates for
GnTI, which adds the first GlcNAc residue to the N-linked glycan core mannose.
The peaks corresponding to hybrid and complex glycans increase in molecular
weight as Golgi transferases add successively GlcNAc residues, followed by
addition of galactose, fucose and neuraminic acid residues.
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Figure 5. Positive ion MALDI-MS profile of native N-glycans from Mgat 5+/+cells
grown in low glucose medium. ♦ High mannose sugars; • Mannose, "GlcNAc,
• Galactose, > Fucose
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Bi-antennary and tri-antennary structures were found in Mgat 5+/+ native
glycan mixtures while the tetra-antennary peaks show very low intensity or
coincide with predominant high mannose peaks. Although neuraminylated sugars
may be present in the mixture, they could not be detected in positive ion mode.
Interestingly, oligosaccharides bearing galactose extensions to the [Gal(314GlcNAc] unit were encountered in the Mgat 5+/+samples at m/z 1827.6, 1973.6,
2135.5, 2339.4. The Gala1-3Gal structure has been found in mammals except for
great apes (Galili et al. 1988) and has been identified as the major antigen
responsible for hyperacute rejection in xenotransplantation (Kobayashi and
Cooper 1999).
In the glycan profile of Mgat 5+/+GlcNAc supplemented samples, the high
mannose series was still predominant in the spectra but the sugars involved in
the initial steps of the a-mannosidase processing decreased in concentration. At
the same time the peaks for complex gycans increase in abundance (Figure

6

).

The bi-antennary and tri-antennary truncated glycans are the direct products of
GlcNAc transferases and the peaks corresponding to these structures are
elevated in the Mgat 5+/+ GlcNAc supplemented sample. Also, the galactose
substituted bi-antennary and tri-antennary glycans were present in higher
concentrations in this treatment (m/z 1487.9, 1666.0, 1690.6, 1812.0, 1852.7,
2016.0,2031.0,2177.3).
The oligosaccharides bearing galactose extensions to the [G aipi4GlcNAc] unit were found in lower concentrations in the GlcNAc supplemented
cells than in the cells grown in low glucose medium.
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Figure 6. Positive ion MALDI-MS profile of native N-glycans from Mgat 5+/+ cells
grown in low glucose medium supplemented with GlcNAc * High mannose
sugars; * Mannose, "GlcNAc, * Galactose, »Fucose.

These findings show that GlcNAc transferases compete with other
transferases to remodel complex N-glycans. Also, the changes in glycan
abundance in the two Mgat 5+/+ cell treatments suggest that the stimulation of the
hexosamine pathway through GlcNAc supplements can influence N-linked glycan
remodeling.
The profile for Mgat 5'/_ cells grown in low glucose medium presents a high
mannose glycan series similar to the one in Mgat 5+/+ cells (Figure 7). At the
same time, the spectrum shows elevated concentrations of the products of GnTI
and GnTII enzymes (m/z 1139.5, 1285.5, 1341.5, 1388.7). This implies that in

36

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

Mgat 5'/_ cells the initial steps in N-glycan remodeling were activated although the
hexosamine pathway was not stimulated with GlcNAc. These observations are
consistent with the experimental measurements of UDP-GlcNAc concentrations
performed by our collaborators. Their findings indicate that basal UDP-GlcNAc
levels in Mgat 5'/_ cells grown in low glucose were 3-fold greater than in Mgat 5+/+
cells (Lau et al. in prep.). Taken together, these findings suggest that in Mgat 5‘/_
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Figure 7. Positive ion MALDI-MS profile of native N-glycans from Mgat 5'/_cells
grown in low glucose medium * High mannose sugars; * Mannose, "GlcNAc,
« Galactose, >Fucose.

cells the hexosamine pathway is artificially stimulated in the absence of GlcNAc
supplements and promotes activation of the initial steps in N-glycan processing
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catalyzed by GnTI and GnTII. It appears that the Mgat 5 deficiency impairs the
feedback regulation of the hexosamine pathway and N-glycan processing.
Although the elevated UDP-GlcNAc levels are able to influence the initial
steps in the N-glycan remodeling, the synthesis of bi-antennary and tri-antennary
mature glycans is maintained at relatively low levels in Mgat 5'/_ (Figure 7). These
results suggest that in a low nutrient medium the mutant cells are not capable of
overcoming the deficit in the glycosylation pathway.
Analysis of glycans released from Mgat 5'/_GlcNAc supplemented cells
show drastic changes in N-glycan remodeling (Figure

8

). This spectrum presents

%H.
1487.4

1418.4

1690.4

1284.4
1138.4

1341.4
1215.4
935.4

1544.4
1259.4

2015.0

1853.3
1421.1

20 6,9,
1056.4
976.4

1122
10 7.4

■ * 1 .4

14 2 !

1218.4

1584.4

.

2056.3

665.3

UT
1000

1100

1200

1300

1 400

1 500

1900

1600

2000

2100

2381.3

2200

Figure 8. Positive ion MALDI-MS profile of native N-glycans from Mgat 5'/_cells
grown in low glucose medium supplemented with GlcNAc. • High mannose
sugars; •Mannose, "GlcNAc, • Galactose, >Fucose.
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a total reverse in the proportion between the high mannose and hybrid and
complex type N-glycans. While the high mannose glycans decrease to one third
in relative abundance, the truncated bi-antennary and tri-antennary glycans
become the predominant peaks in the spectrum (m/z 1341.4, 1487.4, 1544.4,
1690.4).
Oligosaccharides carrying four GlcNAc residues (m/z 1893.4, 2055.3,
2218.4) were encountered in Mgat 5_/'G lcN A c supplemented cells in elevated
concentrations compared to the other treatments where these structures are
present in low concentrations or even absent. I speculate that, due to the GnTV
deficit these cells could not synthesize the tetra-antennary truncated glycans
unless the excess UDP-GlcNAc is able to overcome the energy activation barrier
of the Mgat 5 enzyme. The detailed structure of the oligosaccharides with four
GlcNAc substituents attached to the core could not be determined before
derivatization by permethylation.
As in the Mgat 5+/+ GlcNAc supplemented cells, the oligosaccharides
bearing galactose extensions to the [Gaipi-4G lcNAc] unit were found in low
concentrations or were absent from this treatment. Their low abundances could
suggest that the GlcNAc supplements could determine a preferential capping
with neuraminic acid of the non-reducing N-glycan termini.
The truncated structures with two, three and four GlcNAc substituents
have the highest relative concentrations in the glycan mixture extracted from
these cells and are direct products of GlcNAc transferases. These findings show
that the GlcNAc supplements regulate N-linked glycan remodeling through
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stimulation of the hexosamine pathway and increased concentrations of UDPGlcNAc. Even more, the impaired regulatory feedback from Mgat 5'/_sustains
biosynthesis of truncated complex glycans and accumulation of these structures
in the cells.
The native N-glycan profiling illustrates the interdependency between the
hexosamine pathway and N-linked glycan remodeling, but the detection of
mature neuraminylated oligosaccharides was not possible using this method. For
identification of high molecular weight glycans and for detailed structural analysis
the oligosaccharides from each cell treatment were submitted to methylation.
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CHAPTER 4

METHYLATED N-GLYCAN PROFILING

Methylation is used to improve the analytical properties of oligosacchrides
because it confers several advantages for the mass spectrometric analysis.
Methylation enhances carbohydrate detection by extracting the lipophilic
products into non-polar solvents thereby purifying the glycans from polar
biological components. Glycan methylation with methyl iodide can be catalyzed
by methylsulfenyl carbanion (Hakamori 1964) or by sodium hydroxide (Ciucanu
and Kerek 1984). The hydroxyl group base-catalyzed ionization method was
used for derivatization of oligosaccharides extracted from the Mgat 5 cells with
different GlcNAc treatments. The reaction was carried out under controlled
conditions of humidity and increased the molecular weight of oligosaccharides by
replacement of all labile protons in hydroxyl, carboxyl, and amide groups with
methyl.
Moreover, molecular disassembly of methylated sugars produced by
collision induced dissociation (CID) facilitates a comprehensive structural
understanding of branching and linkage patterns by resolving between free
hydroxyl groups and those involved in glycosydic bonds (Geyer and Geyer
1994). By transforming the negatively charged carboxyl groups into esters,
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methylation allows detection of acidic glycans through ionization as Na+ adducts
in positive ion mode. In this study, mass spectrometric analysis of native glycans
showed variations in oligosaccharide processing among the four GlcNAc
treatments and Mgat 5 genetic backgrounds and demonstrated a dependency
between glycosylation and the hexosamine pathway. Methylation was employed
to facilitate detection of high molecular weight oligosaccharides and the ones
substituted with acidic monosaccharides. Also, it was used for monitoring the
effects of the Mgat 5 null mutation on N-glycans remodeling.

4.1 Comparative Analysis of Methylated N-linked Glycans

An initial hypothesis takes in consideration the important role of poly-Nacetyl-lactosaminylated glycans in establishing the cell surface lattice. This
hypothesis proposes that the tetra-antennary structures cannot be synthesized in
the Mgat 5'/_ cells and that the signal transduction in Mgat 5'/_ GlcNAc
supplemented cell line was rescued by potentially poly-N-acetyl-lactosaminylated
bi-antennary and tri-antennary sugars. The mass spectrometric analysis of
methylated olygosaccharides seeks identification of those component structures
needed to re-establish the receptor-galectin lattice.
Analysis of methylated N-glycans from the Mgat 5+/+ cells grown in low
glucose medium shows a profile predominated by the high mannose glycan
peaks with an averaged relative abundance of approximately 75% of the
maximum intensity (Figure 9, Appendix A). Also, the spectrum presents a
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relatively high abundance (45% of max. int.) for the pool of bi-antennary glycans
substituted with galactose and neuraminic acid (m/z 2085.5, 2261.5, 2465.3,
2495.2, 2669.5, 2809.5, 2826.4, 2983.4). The tri-antennary glycans (m/z 3071.3,
3228.2, 3275.2, 3619.0, 3635.9, 3793.2, 3979.7) are present in relatively low
concentrations, approximately 10% of the maximum intensity. The tetraantennary structures show an even lower relative concentration (4% of max.int.)
and present variations in the degree of neuraminylation (m/z 4086.3, 4242.5,
4288.8, 4446.2, 4602.6). Although the averaged relative abundance of poly-Nacetyl-lactosaminylated sugars is less than

1

% of maximum intensity, these

structures present similar variations in the galactosylation and neuraminylation
patterns as the bi-, tri- and tetra-antennary glycans. The panel in the upper right
corner of Figure 9 shows an expanded view of the mass range between m/z
3600 and 6000. Over this region the poly-LacNAc oligosaccharides show an
increase in molecular weight starting from m/z 4737.0 and they could be detected
up to m/z 7000.
In Figure 9 only one possible structure is associated with each
oligosaccharide peaks. However, the LacNAc or galactose extensions could be
attached in different positions than the ones depicted here. Also, some of the
peaks could be generated by ionization of compounds with identical molecular
weights but different structures. Many of these oligosaccharides were analyzed
by molecular disassembly and the structural details are presented below. Even
though most of the N-glycans in Mgat 5 cell lines could be identified, branch
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Figure 9. Positive ion MALDI-MS profile of methylated N-glycans from Mgat 5+/+cells grown in low glucose medium
•High mannose sugars; * Mannose, ■GlcNAc, • Galactose, >Fucose, ^Neuraminic acid.

localization of galactose or LacNAc terminations was impeded by the very low
concentrations of high molecular weight glycans.
Different features of the glycosylation pathway could explain the step wise
decrease in concentration of the bi-, tri-, tetra- antennary and poly-LacNAc
structures. First, the downstream GlcNAc transferases use as substrates the
reaction products generated by the transferases situated upstream, which limits
the available substrate at each transformation step. Second, the GlcNAc quantity
present in the Golgi at any given time could be a limiting factor for synthesis of
high molecular weight glycans. The absolute time spent by the nascent
glycoproteins in the Golgi may determine the N-glycan remodeling especially
because the affinity of GlcNAc transferases for UDP-GlcNAc decreases along
the glycosylation pathway.
The profile of methylated N-glycans from Mgat 5+/+cells supplemented
with GlcNAc exhibited the predominant series of high mannose glycans, but also
increased concentrations of complex structures (Figure 10). The bi-antennary
glycan pool (m/z 2261.3, 2448.3, 2622.3, 2809.3, 2983.4) had a relatively high
concentration and was composed mostly of structures substituted at the non
reducing end with neuraminic acid. The oligosaccharides carrying galactose
extensions to the [Gal(31-4GlcNAc] unit have very low concentrations or are
absent. The tri-antennary sugars have relatively higher concentrations than the
ones from Mgat 5+/+ cells grown in low glucose media. The tetra-antennary and
poly-LacNAc structures are present in low relative abundances and most of them
lack the galactose extensions.
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Figure 10. Positive ion MALDI-MS profile of methylated N-glycans from Mgat 5+/+cells grown in low glucose medium
supplemented with GlcNAc * High mannose sugars; * Mannose, "GlcNAc, * Galactose, >Fucose, ❖Neuraminic acid

A comparison between the high molecular weight glycan profiles from
Mgat 5+/+ cells grown in low glucose medium and Mgat 5+/+ cells supplemented
with GlcNAc shows the presence of tetra-antennary and poly-N-acetylLactosaminylated structures in both treatments. In Figure 11 the
oligosaccharides carrying the galactosyl extension to the [Galp1-4GlcNAc] unit
are marked with the symbol I. The structures marked with 2XI have two
galactosyl extensions.
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Figure 11. Tetra-antennary and poly-N-acetyl-lactosamine structures.
A) Mgat 5+/+cells grown in low glucose media. B) Mgat 5+/+cells
supplemented with GlcNAc. * Galactose.
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In the Figure 11, the unmarked peaks correspond to the tetra-antennary
and poly-N-acetyl-lactosylated glycans with various neuraminic acid extensions.
The reduced frequency of galactose extensions in Mgat 5+/+ cells when
supplemented with GlcNAc was observed not only for tetra-antennary and polyLacNAc structures, but also for bi- and tri-antennary ones. This suggests that the
increased GlcNAc quantities transported to the Golgi make the GlcNAc
transferases more effective in competing with other glycosyltransferases for the
acceptor substrate. Although the signal transduction is functional in the cells
from both treatments, the receptor glycoprotein - galectin lattice appears to be
generated by slightly different structures.
Profiles of methylated N-glycans from Mgat 5_/'ce lls grown in low glucose
medium (Figure 12) show the high mannose glycans series in elevated
abundnces. Also, the truncated sugars synthesized by GnTI and GnTII (m/z
1433.4,1607.8, 1678.6, 1852.7) were found with increased relative abundances,
which suggests that loss of feedback from Mgat 5 modified glycans and defective
interactions established in the absence of these structures stimulated the cells to
activate the hexosamine pathway as a compensatory mechanism. The bi- and triantennary glycan pools were present in relatively low concentrations, but similar
to the ones found in Mgat 5+/+cells. The tetra-antennary oligosaccharides,
synthesized by the GnTV enzyme, are characterized by molecular weights over
4000 amu and were absent from Mgat 5_/' cells (expanded panel). Also, the polyN-acetyl-lactosaminylated sugars could not be detected in this sample,
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Figure 12. Positive ion MALDI-MS profile of methylated N-glycans from Mgat 5 " cells grown in low glucose medium
# High mannose sugars; * Mannose, "G lcNAc, * Galactose, > Fucose, ❖Neuraminic acid.

consistent with the LacNAc extensions being attached preferentially to the tetraantennary structures synthesized by Mgat 5. Although it is possible for Mgat 5-/cells to synthesize bi- and tri-antennary poly-N-acetyl-lactosaminylated sugars,
their very low concentrations, if existent, coupled with the degradative, strong
base conditions imposed by the permethylation reaction could make these
structures fall below the detection limits. Absence of tetra-antennary and polyLacNAc oligosaccharides from these cells impairs lattice formation, signal
transduction and the oncogenic potency of PyMT background.
In the profiles of methylated N-glycans from Mgat 5_/" cells supplemented
with GlcNAc, the abundance of high mannose glycan series decreases to
approximately one third of that encountered in the other treatments (Figure 13).
At the same time the relative abundance of complex type glycans increases
dramatically. In these cells, as in Mgat 5'7'ce lls grown in low glucose media, the
products ofG nTI (m/z 1433.9, 1608.0) and GnTII (m/z 1679.0, 1853.1) were
highly increased. In addition, stimulation of the hexosamine pathway by the
GlcNAc supplements supplies the cells with large quantities of UDP-GlcNAc and
sustains increased reaction rates for the GlcNAc transferases situated down
stream in N-glycosylation, as well. This generates high concentrations of glycans
with three GlcNAc substituents (m/z 1924.4, 2096.6) and four GlcNAc
substituents (m/z 2343.7). Galactosyl-transferases and neuraminyl-transferases
use these structures as substrates and synthesize olygosaccharides with various
proportions of the neuraminylated [Gaipi-4GlcNAc] unit.
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Figure 13. Positive ion MALDI-MS profile of methylated N-glycans from Mgat 5'/_cells grown in low glucose medium
supplemented with GlcNAc. * High mannose sugars; "Mannose, "GlcNAc, * Galactose, >Fucose, Neuraminic acid.

GlcNAc supplements rescued receptor interaction with the lattice and the
cytokine signaling in these cells, but the anticipated galectin-3 preferred ligands
were not present in the spectra. Absence of bi- and tri-antennary poly-N-acetyllactosaminylated oligosaccharides (expanded panel in Figure 13) suggests that
the invasive phenotype manifested by these cells was reinstated by a cell surface
lattice generated through alternative structures.
Presence of the glycan bearing four GlcNAc residues attached to the core
(m/z 2343) was intriguing. Although it is explainable by the high UDP-GlcNAc
concentration which increases the effective reaction rate of GlcNAc transferases,
this glycan could not be a tetra-antennary truncated structure because GnTV is
not functional. To acquire structural details about this carbohydrate and to
confirm peaks annotation the methylated glycan mixtures were submitted to
molecular disassembly by collision induced dissociation.

52

R eproduced with perm ission o f the copyright owner. F urther reproduction prohibited w itho ut perm ission.

CHAPTER 5

DETAILED STRUCTURAL ANALYSIS BY
COLLISION INDUCED DISSOCIATION

Multi-dimensional Mass Spectrometry (MSn) and Collision Induced
Dissociation (CID) have been coupled in an ion trap instrument for the isolation
and characterization of gas phase components of a complex mixture. Repeated
cycles of ion isolation and dissociation in an ion trap can be performed until the
large bio-molecules are reduced to their basic units. The bio-molecules can then
be identified by interpreting the fragmentation patterns for each MSn step or by
matching them against a fragment library of standard compounds. The resulting
spectra reveal molecular composition and structural details regarding a
biopolymer sequence as well as branching and linkage position for
oligosaccharides (Reinhold e ta l. 1995; W eiskopf et at. 1997). More recently,
features of anomericity and monomer identification have been available using
such strategies (Zhang, Singh and Reinhold 2005). These methods have been
employed for characterization of linear molecules like DNA (Walters et at. 2002),
proteins and peptides (Hunt et al. 1986), as well as more complex structures like
glycosphingolipids (Reinhold eta l. 1994; Levery 2005) and oligosaccharides
(Sheeleyand Reinhold 1998; Harvey ef al. 1996).
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5.1 Multi-dimensional Mass Spectrometric Analysis of the Chicken
Ovalbumin Glycans

Glycans released and profiled by mass spectrometry generate an array of
ions representative of each glycoprotein. As an example, the glycoprotein from
chicken egg white ovalbumin has only one glycosylation site, but due to micro
heterogeneity, the released oligosaccharide spectrum exhibits more than 20
different peaks with known isobaric structures (Harvey et al. 2000). For
component identification of this complex mixture, multi-dimensional mass
spectrometry could be used directly for structural analysis of each individual peak
without requiring a previous chromatographic separation.
In MS2, the ion of interest is selected from the mass profile and retained in
the ion trap, while all other ions are swept away. This precursor ion is then
collided with an inert gas and the product fragments are mass profiled. Usually at
this level, the fragment ions generated are simple glycosidic bond cleavages.
In a series of subsequent MSn steps, product ions are selected and fragmented
further with generation of monosaccharide cross-ring cleavages which are
informative of linkage and branching patterns. Parallel and successive cycles of
isolation and dissociation can generate a tree of structural information with
ramifications for each of the parent ion fragments (Zhang et al. 2005).
Multi-dimensional mass spectrometry of the chicken ovalbumin glycan at
m/z 2168.8 (Figure 14) uncovers a mixture of four isomers (isobars) within the
same ion peak (Geiser et al. 2006). Detailed analysis was pursued in four
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o

(isolation and CID) steps. During MS2 four GlcNAc residues were cleaved
(neutral losses) from the non-reducing end as well as one from the reducing-end
GlcNAc. The latter residue was distinguished by its different mass which was
acquired upon NaBH4 reduction.
The total mass loss of 1,331 amu in the MS2 step generates a product ion,
m/z 838, which corresponds to the tri-mannosyl-GlcNAc core. This ion was
selected for further dissociation in the MS3 step and generated a series of cross
ring key fragment ions indicative of the branching pattern.
Identification of two pairs of counterpart ions, m/z 662 and 620, as well as
m/z 648 and 634 indicates the presence of two pairs of bisected isobars (Figure
15). In MS4 of m/z 2168, following the pathway, m/z 2168-*- 838-N311, only the
tri-mannosyl core was fragmented and the cross ring cleavages of the middle
mannose uncovered a set of four isobars with different GlcNAc distributions on
the a-1,3 and a -1 ,6 core mannoses. The ion at m/z 444 indicates presence of a
free hydroxyl group on the middle mannose produced by the loss of a bisecting
GlcNAc. This study shows that in-depth structural analysis is required for
comprehensive carbohydrate identification.
Detailed structural characterization is important because oligosaccharides
establish unique interactions with different types of lectins and modulate various
biological processes. Many lectins recognize specific glycan structures or
conformations, types of monosaccharides or linkage positions. Acquiring detailed
structural information about the lectin’s ligands is of great value in understanding
the types of interactions they generate and the biological functions they regulate.
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5.2 Structural Analysis of Bi-, Tri- and Tetra-antennary Glycans by
Collision Induced Dissociation

The complex glycan mixture released from total cell proteins in the Mgat 5
treatments makes it difficult to unambiguously identify the oligosaccharide’s
structures. Collision Induced Dissociation was employed for identifying the Nlinked glycans and for resolving the carbohydrate peaks with identical molecular
weight values and composition but with different structures referred to as isobars.
Also, CID was used to support peak identification predicted by GlycoMod and to
resolve between the multiple hits to GlycoSuite Data Base.
Collision Induced Dissociation in the MALDI QIT instrument provides
adequate sensitivity for low sample quantities. However, a comprehensive
analysis using repeated fragmentation cycles during multi-dimensional mass
spectrometry requires elevated concentrations of oligosaccharides because the
interfering background noise increases with the decrease of glycan
concentration.
The decreasing activity of GlcNAc transferases as the glycosylation
pathway advances produces much lower quantities of the high molecular weight
compounds. Correlated with the requirements for tandem mass spectrometry,
structural determination of low abundance high molecular weight glycans
becomes a challenging problem. For this, the spectra were acquired either
manually by conducting the laser shots in areas rich in desired analyte or
automatically by accumulating a few thousands profiles for one spectrum.
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In Mgat 5 cells the partially and fully decorated oligosaccharides generate
very rich methylated spectra. Although the tetra-antennary and poly-N-acetyllactosaminylated structures could be identified in the Mgat 5+/+ cells, these were
absent from Mgat 5'7'cells. An initial hypothesis suggested that in an Mgat 5
deficient background, the GlcNAc supplements would reestablish the lattice
interaction and signal transduction by facilitating biosynthesis of bi- and triantennary poly-N-acetyl-lactosaminylated glycans. These types of structures
could be identified neither in Mgat 5+/+ cells nor in Mgat 5'/_ cells. However, due to
similarities in their monosaccharides composition the bi-antennary glycans with
one N-acetyl-lactosamine extension are molecular weight isomers with the triantennary glycans. In the same way, the tri-antennary glycans with one N-acetyllactosamine extension are isomers with tetra-antennary ones. Also, the biantennary sugars with two N-acetyl-lactosamine extensions are isomers with the
tetra-antennary glycans. To resolve these isomeric structures and the multiple
alternatives introduced by GlycoMod predictions and to identify the role of bi- and
tri-antennary poly-N-acetyl-lactosaminylated sugars in establishing the cell
surface lattice, various glycans from the different Mgat 5 treatments were
subjected to CID.
Within a mass tolerance of only two Daltons a GlycoMod search gave two
different hits in GlycoSuite DB for the molecular ion at m/z 2983 (Figure 12). One
possible composition corresponds to a bi-antennary mature glycan (Hex)2
(HexNAc)2 (Deoxyhexose)i (NeuAc)2 + (Man)3(GlcNAc)2 with two
neuraminylated branches attached to the N-glycan core (Man)3(GlcNAc)2 and a
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fucosylated reducing end. The second possibility is a tetra-antennary without any
neuraminic acid orfucose substituents (Hex ) 4 (HexNAc ) 4 + (Man)3(GlcNAc)2
(Figure 16).

(Hex ) 2 (HexNAc)2 (Deoxyhexose)i

(Hex ) 4 (HexNAc ) 4 +

(NeuAc ) 2 + (Man)3(GlcNAc)2

(Man)3(GlcNAc)2

Figure 16. N-glycans predicted by GlycoMod for m/z 2983.

To identify the structure of the N-glycan at m/z 2983 the parent ion was
fragmented by CID. The molecular dissociation profile shows successive neutral
losses of two neuraminic acid residues and two [Gal-GlcNAc] units (Figure 17).
The fragmentation pattern generates a specific core ion at m/z 867 and identifies
this N-glycan as a bi-antennary structure. It has been shown before that during
molecular disassembly experiments the predominant ion peaks are generated by
cleavage of the most labile glycosidic bonds established by GlcNAc and
neuraminic acid residues (Zaia 2004).
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Figure 17. Bi-antennary glycan - MS2 m/z 2983; »Mannose, "GlcNAc,
• Galactose, »Fucose, oNeuraminic acid.

Another GlycoMod search proposed two structures for the ion m/z 3023.
One possible structure (Hex)9 + (Man)3(GlcNAc)2 could be the initial high
mannose glycan GlcNAc 2 MangGIC3 transferred by the oligosaccharyltransferase
complex from the dolichol-phosphate to the nascent proteins in the ER lumen
(Figure 2). A second proposed structure could be either a bi-antennary or a triantennary glycan (Hex)1 (HexNAc)3 (Deoxyhexose)l (NeuAc)2 +
(Man)3(GlcNAc)2.
MS2 dissociation of the ion m/z 3023 shows specific fragment ions and
neutral losses indicative of a bi-antennary structure (Figure 18). Although, the
GalNAc - GlcNAc group (Lac-di-NAc) is not very common in mammals, the
fragmentation pattern proves its presence in a bi-antennary glycan.
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Figure 18. Bi-antennary glycan - MS2 m/z 3023; »Mannose, "GlcNAc,
* Galactose, ^Fucose, « Neuraminic acid, ■ GalNAc.

Methylated oligosaccharides exhibit a preferential rupture proximal to the
reducing end of HexNAc that generates a mixture of B-type and Y-type ions
(Domon and Costello 1988) with approximately equal abundances (Egge et al.
1983). The glycosidic rupture induces formation of an unsaturated bond on the
non-reducing terminal ion and a free hydroxyl group on the reducing terminal ion
An exception from this pattern is cleavage of the 1-3 linkage which ruptures on
the reducing side of the glycosidic oxygen leaving the point of unsaturation on
the reducing terminal ion. These marks left behind after glycosidic bond
breakage give information about branching and linkage. Monitoring these ions
and neutral loss fragments greatly aids in understanding of structure. For
example, a terminal monosaccharide neutral loss acquires a unique mass when
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positioned at the reducing end, due to unsaturation. Internal residues acquire two
modulations in mass, due to glycosidic ruptures at the reducing end and the non
reducing end. Also, each ramification point imposes an additional alteration in the
neutral loss mass.
Molecular weight calculation and empirical observations of fragmentation
patterns from many other bi-antennary structures (results not presented) show
that glycans with two substituted hydroxyl groups on the core generate a specific
tri-mannosyl ion at m/z 866 (Figure 17 and Figure 18). This ion served as a
structural fingerprint for all glycans with two GlcNAc substitutions on the core
because it was produced independent of antenna extension or reducing end
fucosylation.
When colliding the ion peak at m/z 3618, three neutral losses of terminal
neuraminic acid residues were observed (Figure 19). Also, the molecule lost
three internal Gal-GlcNAc units and a reducing-end GlcNAc. The trimannosyl
core fragment ion m/z 853 indicated three free hydroxyl groups at the non
reducing end which is indicative of the number of antennae and one double bond
at the reducing end GlcNAc. This fragmentation pattern and the specific core ion
identified the structure at m/z 3618 to be a tri-antennary not fucosylated
oligosaccharide.
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Unlike the previous structure, fragmentation of the oligosaccharide at m/z
3823 showed a neutral loss of a fucosylated reducing end GlcNAc (Figure 20).
Also, the molecule lost two terminal N-acelyl-neuraminic acid residues, one
terminal N-glycolyl-neuraminic acid and three intercalated Gal-GlcNAc residues.
This summation provides strong indication for a tri-antennary structure. Although
one of the antennae carries a different substitution than the previous structure
and the reducing end is fucosylated, the tri-mannosyl core ion has the same
molecular weight. This shows that, independent of its composition, a glycan
bearing three substituents on the core, including the tri-antennary sugars, can be
reduced to the same fingerprint ion (m/z 853).
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N-Glycolyl neuraminic acid is an analog of N-acetyl neuraminic acid and
has one extra hydroxyl group which gains a methyl group after methylation
(Figure 21). The two analogues could both be referred to as sialic acids.

HQCH-,

HOCH2

COOH

COOH

HOH-iCOCHN

H.,COCHX

/V-Acctylncuraminic A cid
(NeuSAc)

iV-Glycoiylneuramtnic Acid

(NeuSGc)

Figure 21. Different neuraminic acid residues.
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N-glycolyl neuraminic acid is a common component of glycoconjugates in
murines and other mammals and participates in formation of the blood group
epitopes in canines and felines. Also, N-glycolyl neuraminic acid is recognized
and modulates binding of different viruses in animals (Vihinen-Ranta et al. 2004).
The hydroxylase that modifies this monosaccharide is expressed in great apes,
but the enzyme and its product are absent from human cells generating
variations in susceptibility to viral infections among primates (Muchmore et al.
1998). Also, traces of N-glycolyl neuraminic acid were found in tumor cells in
humans and the monosaccharide has been investigated as a possible cancer
biomarker (Varki 2002).
For oligosaccharides of large size, comprehensive branching and linkage
determination requires three or four multi-dimensional mass spectrometry steps
and relatively large sample concentrations. Most of the high molecular weight
glycans were present in the Mgat 5 cells in very low concentrations (see relative
abundances of glycans at m/z 3023, 3823 and the tetra-antennary sugars in
Figures 9, 10, 12 and 13) and do not allow numerous steps of molecular
fragmentation. Although not a detailed analysis, the structural fingerprinting
method described above resolves between bi-antennary glycans with one Nacetyl-lactosamine extension and tri-antennary isomers, as well as tri-antennary
glycans with one N-acetyl-lactosamine extension and their tetra-antennary
isomers.
Characteristic fingerprint ions were identified in the tetra-antennary glycan
pool. For example, dissociation of the glycan at m/z 4445 indicated four
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alternative fragmentation patterns, three of which are marked in Figure 22 and
one is left unmarked.

MS24445 Mgat5+/4

1288.3
V

Mmoagt
Figure 22. Tetra-antennary glycan - MS2 m/z 4445; *Mannose, "GlcNAc,
• Galactose, >Fucose, p Neuraminic acid.

Antennae heterogeneity and alternative cleavage sites introduced by the
Gal-Gal unit generate a rich fragment ion density in this spectrum. Neutral losses
during dissociation identify four terminal residues and three internal Gal-GlcNAc
disaccharides. Independent of the cleavage succession, all fragmentation
pathways converge to the fingerprint ion at m/z 1288.3. The tri-mannosyl core
has three free hydroxyl groups at the non-reducing end and one Gal-GlcNAc unit
with one free hydroxyl, which means that the glycan has four substituents
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attached to the core. Together with the fragmentation patterns, the fingerprint ion
identifies the oligosaccharide as a tetra-antennary structure.
Similar dissociation patterns were observed for the glycan at m/z 4603
(Figure 23), although the spectrum shows fewer fragment ions due to identical
mass of each antennae, which create a homogeneous non-reducing side.
During molecular disassembly the molecule loses the fucosylated reducing end,
four N-acetyl-neuraminic acid residues and three Gal-GlcNAc units. The
remaining tri-mannosyl core was identical to the one found in previously
described structure (Figure 22) and was considered a fingerprint ion for the tetraantennary sugars.

2113.4

4135.1

2133.

1474.2

m m

Figure 23. Tetra-antennary glycan - MS2 m/z 4603; "Mannose, "GlcNAc,
• Galactose, >Fucose, ❖Neuraminic acid.
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The low concentration of the high molecular weight glycans does not
permit a multiple step molecular dissociation. The ion fingerprinting method
allowed identification of almost all glycans in the Mgat 5 tumor cells (results not
presented). Also, possible isomers with the poly-N-acetyl-lactosaminylated
structures could be differentiated with ease using this strategy. For example, the
glycan at m/z 5052.3 in the Mgat 5+/+ GlcNAc supplemented cells has a relative
abundance of less than 1% from the maximum abundance. However, the
fragmentation pattern shows an identical core ion as the structure at m/z 4603
and also an extra neutral loss of a Gal-GlcNAc unit. These findings identify the
glycan at m/z 5052 as a tetra-antennary glycan with one N-acetyl-lactosamine
extension and not a penta-antennary isomer (Figure 24).

m/z 4603
Tetra-antennary

m/z 5052

m/z 5052
Tetra-antennary poly-LacNAc

Penta-antennary

Figure 24. Isomer identification for m/z 5052.

Screening the glycan mixtures from the Mgat 5 tumor cells with different
genetic backgrounds and GlcNAc treatments identified bi-, tri- and tetraantennary glycans as well as poly-N-acetyl-lactosaminylated tetra-antennary
structures in both GlcNAc treatments for Mgat 5+/+cells. A similar analysis for the
Mgat 5'/_cells showed only bi- and tri-antennary glycans and none of the tetra-
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antennary structures synthesized by GnTV or the tetra-antennary poly-N-acetyllactosaminylated ones.
An initial hypothesis suggested that the GlcNAc supplements to the Mgat
5';' tumor cells could rescue the lattice interaction by facilitating addition of polyN-acetyl-lactosamine extensions to the bi- and tri-antennary glycans. Although
cytokine signal transduction was restored by the GlcNAc supplements, none of
the poly-LacNAc bi- or tri-antennary glycans could be identified in the Mgat 5'/_
GlcNAc supplemented cells.
The poly-N-acetyl-lactosaminylated oligosaccharides show low
concentrations in the Mgat 5+/+ cells and perform their biological activities though
interactions of high affinity rather than high avidity. The branch GlcNAc p-1,6
Man a-1,6 Man initiated by Mgat 5 activity is not required for addition of poly-Nacetyl-lactosaminylated extensions. However, this branch generates preferred
substrates for GnT(i), the GlcNAc transferase which adds the poly-LacNAc
extensions and promotes carcinogen transformation (Pierce and Arango 1986;
Dennis et al. 1987). This metabolic bias generates an increase in poly-N-acetyllactosaminylation for the Mgat 5 modified glycans in comparison to the bi- or triantennary sugars. Also, the lower affinity of GnT(i) for bi- and tri-antennary
glycans explains the absence of poly-LacNAc extensions on these structure in
the Mgat 5'/_ tumor cells. Although the detection of these structures was not
possible their presence in the Mgat 5'1' cells cannot be totally excluded. However,
if bi-antennary and tri-antennary glycans with poly-LacNAc extensions are
synthesized in these cells, they are present in extremely low concentrations and
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may not be able to reestablish lattice formation and signal transduction by
themselves (Lau. eta l. in prep.)
These findings forced us to reevaluate the mechanisms of lattice formation
and to search for alternative structures, which could rescue signal transduction in
Mgat 5'/_tum or cells grown in GlcNAc supplemented medium.

5.3 GlcNAc Transferase Products Compete or Cooperate?

The molecular dissociation experiments allowed partial structural
assignments for most of the oligosaccharides found in Mgat 5 tumor cells and an
identification of high molecular weight galectin-3 ligands, which establish the cell
surface lattice in Mgat 5+/+ cells (Partridge et al. 2004). However, the structures
that rescued signal transduction in Mgat 5'/_ cells supplemented with GlcNAc
could not be identified.
A reevaluation of the native and methylated glycan spectra pointed out the
major differences among the four Mgat 5 tumor cell treatments. The tetraantennary and poly-N-acetyl-lactosaminylated structures were found in both
GlcNac treatments for Mgat 5+/+ cells, but not in the lattice deficient Mgat 5'/_ cells
grown in low glucose media. This demonstrates their essential role in modulating
signal transduction by establishing the galectin - receptor glycoprotein
superstructure. At the same time, the poly-N-acetyl-lactosaminylated glycans
were absent from the Mgat 5'/_ cells rescued by GlcNAc supplements. This shows
that poly-N-acetyl-lactosaminylation is not favored in an impaired Mgat 5
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background. These findings suggest that the GlcNAc supplements to Mgat 5_/'
cells reestablished the lattice formation by promoting biosynthesis of alternative
structures with similar properties.
A search for large variations in oligosaccharide properties among the four
Mgat 5 GlcNAc treatments showed an important difference in the amount and
distribution of the glycans carrying the Gal-Gal-GlcNAc antenna between the
Mgat 5+/+ cells grown in low glucose media and the ones supplemented with
GlcNAc. The terminal galactose residue was found preponderantly in Mgat 5
cells grown in low glucose media, while the GlcNAc supplemented cells had a
higher incidence of neuraminic acid terminal residues. It is known that neuraminic
acid capping can influence various biological phenomena, including cell-cell
interactions, binding of toxins, viruses, bacteria, and parasites to their cellular
receptors, as well as maintaining stability and biologic activity of hormones or
enzymes in vivo (Oetke et al. 2002). It may be possible that the terminal
neuraminic acid is favored for lattice binding and could offer an advantage in
establishing signal transduction in GlcNAc supplemented samples. However, the
cell surface superstructure was functional in both Mgat 5+/+GlcNAc treatments,
although the glycans display marked differences in terminal capping. This makes
it difficult to estimate the role of the different termini in the interactions with
galectin-3, but suggests a lattice’s plasticity and its ability to interact with
alternative structures.
One major variation among the four types of analyzed cells and GlcNAc
treatments was the extensive increase in the relative abundance of glycans with
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one, two, three and four GlcNAc residues attached to the trimannosyl core in
Mgat 5~/_GlcNAc supplemented cells. It would be expected to see these Nglycans in elevated concentrations because these are the direct products of
GlcNAc transferases and the GlcNAc supplements sustain their biosynthesis by
generating large quantities of high-energy donor molecules. However, the glycan
with four GlcNAc substituents, a possible precursor to a tetra-antennary
structure, was not expected in these cells due to the Mgat 5 null background. A
tandem mass spectrometry analysis of the sugars with three and four GlcNAc
residues attached to the core (m/z 2098 and 2343, in methylated spectra) from
the Mgat S'^GIcNAc supplemented cells identified their structure and raised
additional questions.
Collision induced dissociation of the glycan at m/z 2098 showed in MS2
successive neutral losses of a fucosylated reducing end and three non-reducing
GlcNAc termini (Figure 25). Also, this fragmentation generates the fingerprint ion
for glycans with three core substituents (m/z 852.5). A predicted molecular
structure and the fragmentation points are depicted in Figure 26. The fragment at
m/z 1838 could be produced by glycosidic cleavage of either of the terminal
GlcNAc residues. Although the MS2 fragmentation informs about the
monosaccharide composition, it could not identify the distribution of the GlcNAc
substituents on the core mannose residues. To accomplish this, the core ion was
dissociated in the MS3 step.
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Dissociation of the core ion in MS3 showed fragmentation patterns
indicative of a mixture of two isomers with different substituent distribution for the
core mannoses (Figure 27). The ion pair at m/z 662 and 648 indicated that the a1,3 and a-1,6 core mannoses establish glycosidic bonds with a different number
of substituents and suggest the presence of a tri-antennary structure. At the
same time the ion pair at m/z 458 and 444 indicated that two isomers are
present, one has the position (3-1,4 of the middle mannose involved in a
glycosidic linkage and a second isomer has a methylated hydroxyl group at the
same position. The fragmentation patterns of the core ions are presented in
Figure 28 and 29.
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Figure 27. Core ion fragmentation; MS3 m/z 2098
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Figure 28. Core ion fragmentation for the tri-antennary precursor.
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Figure 29. Core ion fragmentation for the bisected glycan.
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One component of the mixture was the predicted tri-antennary precursor
with two GlcNAc residues attached to the a - 1 ,3 core mannose and the third
GlcNAc residue linked to the a - 1 ,6 core mannose (Figure 28). A second
component present in the mixture carries one GlcNAc residue attached to the a 1 ,3 core mannose, the second GlcNAc residue linked to the a - 1 ,6 core mannose

and the third GlcNAc linked in (3-1,4 of the core middle mannose (Figure 29). This
bisecting GlcNAc is attached by GlcNAc transferase III (GnTIII) activity
(Narasimhan 1982) and its presence on the core inhibits the activity of other
glycosyl transferases as well as mannosidases, rendering the glycan of an
unprocessed type (Schachter 1986).
When colliding the ion at m/z 2343 the fragmentation pattern showed
neutral loses of a fucosylated reducing end and also loss of four terminal GlcNAc
residues (Figure 30). The proposed structure for this bisected glycan was
depicted in Figure 31.
The core ion at m/z 838 was dissociated in MS3 (Figure 32) and indicated
losses of core mannoses with one substituent (m/z 634) and two substituents
(m/z 648). Presence of another key fragment ion (m/z 444) showed that the core
middle mannose has three substituents attached. These are the a - 1 ,3 and a - 1 ,6
mannoses and the p - 1 ,4 bisecting GlcNAc (Figure 33). Absence of the ion at m/z
458 (Figure 28) from the MS3fragmentation showed that the peak at m/z 2343
was generated by a single oligosaccharide with a bisecting GlcNAc core.
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Identification of a single bisected glycan at m/z 2343 showed that, in the
absence of GnTV activity, the Mgat 5'/_cells cannot synthesize the tetraantennary structures and that the GlcNAc supplements cannot overcome the
energy activation barrier for this enzyme. However, GlcNAc supplementation
increases the activity rate of all other GlcNAc transferases including the bisecting
enzyme GnT III.
Expression of GnT III enzyme was found to be elevated in brain and
kidney cells from mice and humans, but was present at relatively low levels in
other tissues (Bhattacharyya et al. 2002). Regulation of GnT III activity and its
glycan products proved to be tissue specific. In Mgat 5+/+cells grown in low
glucose medium, the bisected glycans were present at very low concentrations,
which shows that these structures are not required for signal transduction. The
GlcNAc supplemented cells, and especially the Mgat 5'7'ones, showed increased
levels of bisected glycans, which brings into question their role in signal
transduction.
The increased relative abundance of bisected glycans in Mgat S^'GlcNAc
supplemented cells could be only a byproduct of the elevated concentrations of
UDP-GlcNAc, which stimulate all GlcNAc transferase activity. At the same time,
GnT V and GnTIII compete in the trans Golgi for the same acceptor substrate,
the bi- and tri-antennary precursors (Figure 3). GlcNAc supplements, together
with the GnT V deficiency in Mgat 5'1' cells, can produce a phenocopy of GnT III
over-expression with various implications in cell functions. For example, over
expression of GnT III suppressed lung metastasis of melanoma cells by inhibiting
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GnTV activity (Yoshimura et al 1995). Also, expression of both GnT III and GnT
V genes is enhanced during hepatocarcinogenesis, although they are not
expressed in the normal liver (Taniguchi et al. 1999). In the same time, GnT III
transfectants produce spleen carcinoma by offering protection against natural
killer cell cytotoxicity (Yoshimura 1996). Taken together these findings suggest
that the bisected glycans can sustain or inhibit cancer progression through
different cell type specific mechanisms. Although GnT III and GnT V enzymes
compete for the same substrate, the interactions established by their glycan
products can converge or antagonize in supporting or inhibiting specific biological
functions.
The role of bisected glycans in lattice formation and signal transduction, if
any, is poorly understood in Mgat 5 cells. Other experimental approaches may be
required for assessing the effects of enzyme competition and the interactions
established by their products.
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CHAPTER 6

IDENTIFICATION OF ALTERNATIVE GALECTIN-3 LIGANDS
IN Mgat 5 A GlcNAc SUPPLEMENTED CELLS

Mass spectrometric analysis of methylated oligosaccharides from
different GlcNAc treatments of Mgat 5 tumor cells allowed identification of GnT V
products and the galectin-3 ligands in Mgat 5+/+ cells. At the same time, an
absence of poly-N-acetyl-lactosaminylated glycans from the Mgat 5'/_cells implies
that lattice formation and signal transduction were modulated through alternative
interactions in the GlcNAc supplemented samples.
Evaluation of the quantitative and qualitative changes in the
oligosaccharide distribution from Mgat 5'/_GlcNAc supplemented cells showed a
substantial decrease in high mannose glycans concomitant with an increase in
complex type glycans. This shift in the high mannose/complex glycan ratio could
be explained by an increase in glycan remodeling through stimulation of Golgi
GlcNAc transferases and the hexosamine pathway caused by the GlcNAc
supplements. Another explanation could be that the GlcNAc supplements sustain
activity of Golgi GlcNAc transferases including the activity of GlcNAc-1phosphotransferases. This may increase the rate of biosynthesis and transfer of
lipid-linked oligosaccharides to proteins and elevate the number of occupied
glycosylation sites for a given glycoprotein. In the last possibility, the GlcNAc
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supplements may influence the total number of glycans attached to proteins as
well as the number of complex type sugars. However, lattice formation and signal
transduction were influenced by the number of occupied glycosylation sites, as
well as the type of glycan structures present on the receptor glycoproteins, in
other words the density of galectin ligands.
The bioinformatics study by Lau et al. (in prep), which compares the
number of glycosylation sites on the extracellular domain of cell surface
receptors, showed that the receptors involved in cell differentiation and
morphogenesis have fewer glycosylation consensus sites than the growth and
proliferation signal receptors. This implies that the activity of the two categories of
receptors will be affected differently by the interaction with the lattice. For
example, the transforming growth factor-p (TGF-p) receptors TpRI and TpRII
have only one and three N-X-S/T consensus sites, respectively. Mgat5'y' cells
displayed a two- to threefold decrease in sensitivity to TGF-p compared with
approximately 100-fold decrease in sensitivity to EGF, PDGF and IGF (Partridge
et al. 2004). At the same time, Mgat5'/_ cells supplemented with GlcNAc
displayed a full rescue of receptor sensitivity to TGF-p and only a 70% rescue of
receptor sensitivity to anabolic factors (Lau et al. in prep). These results suggest
that the large number of glycosylation sites on the anabolic receptors modulates
the receptor response to cytokines and the lattice sensitivity to GlcNAc
supplements in a gradual manner. Also, the limited number of glycans on
morphogenic receptors causes an ultrasensitive lattice dependency on GlcNAc
supplements and a switch-like receptor activation mechanism.
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To identify the N-linked glycans that generate the lattice interactions and
to determine their quantitative variations, Mgat 5+/+ and Mgat 5_/' cells were grown
in media supplemented with increasing concentrations of GlcNAc. The series of
GlcNAc titrations were identical for both Mgat 5 genetic backgrounds, with
increasing GlcNAc concentrations from 0 to 50 mM.
The oligosaccharides were released from the individual cell cultures,
reduced and directly MS profiled. The native glycan profiles are a more accurate
quantitative representation for neutral oligosaccharides as this avoids ulterior
derivatization and purification which could introduce degradative reactions or
contaminants. However, the oligosaccharides released from the Mgat 5 cells
were a mixture of neutral and acidic species with different ionization properties.
In positive ion extraction, neutral glycans ionize as Na+ molecular ions [M+Na]+,
while the acidic glycans ionize as deprotonated ions [M-H]" and go undetected.
This makes it difficult to detect both ion types in a quantitative manner. Glycan
methylation resolves the ionization problem through esterification of the carboxyl
groups, but could introduce variables associated with derivatization and sample
handling. Also, the methylated glycan profiles show that most of the high
molecular weight sugars are present in very low concentrations, which makes it
difficult to obtain a quantitative estimation.
For these reasons the oligosaccharides from the Mgat 5 cells were
desialylated by non-specific mild acidic hydrolysis. Neuraminic acid release
provides a comparable product for all components in the mixture and
consolidates under one ion peak similarly branched glycans. The signal strength
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of glycans ionized by MALDI appears to reflect accurately the amount of material
on the target, providing that the correct matrix was chosen (Harvey 1993). The
matrix used for ionization of oligosaccharides in Mgat 5 tumor cells was 2,5dihydroxy benzoic acid (DHB), which is known to produce a linear response over
several orders of magnitude (Harvey 1999). A quantitative evaluation of a
standard oligosaccharide dilution series mixed with another standard
oligosaccharide with a constant concentration shows a direct dependence
between the peak intensity and the compound concentration as well as the
intensity variation between the two compared ion peaks (results not shown).
The glycans from each Mgat 5 genetic background were extracted and
profiled before and after neuraminic acid release. The comparison between the
two sets of spectra provides information about the ratio between the low
molecular weight non-sialylated and the high molecular weight sialylated glycans.
A quantitative evaluation was performed among all of the eight GlcNAc
treatments for each titration series.
The glycans released from Mgat 5+/+ cells and their molecular structures
are represented in Figure 34. The oligosaccharide profiles before and after
neuraminic acid release for three of the GlcNAc treatments from the Mgat 5+/+
titration series are presented in Figures 35, 36. and 37.
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Figure 34. Native N-glycans from Mgat 5 +/+, after neuraminic acid release.
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Figure 35. Native N-glycans from Mgat 5+/+grown in low glucose; A - before neuraminic acid release; B - after
neuraminic acid release.
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Figure 36. Native N-glycans from Mgat 5+/+ with 31 mM GlcNAc supplement; A - before neuraminic acid release;
B - after neuraminic acid release.
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Figure 37. Native N-glycans from Mgat 5+/+ with 50 mM GlcNAc supplement; A - before neuraminic acid release;
B - after neuraminic acid release.

In all of the spectra the high mannose glycans are marked with a dot for
an easier comparison. The profiles of native oligosaccharides before neuraminic
acid release are presented in the upper part of the Figures 35, 36 and 37. All of
these profiles show elevated concentrations of high mannose type sugars and
relatively low concentrations of complex type glycans. The oligosaccharide
profiles after neuraminic acid release are presented in the lower part of Figures
35, 36 and 37. Although the concentrations of high mannose glycans remain
relatively constant, the release of neuraminic acid determines accumulation of
bi-, tri- and tetra-antennary glycans under elevated common ion peaks. Tetraantennary and poly-N-acetyl-lactosaminylated structures were identified in these
spectra but in smaller number after neuraminic acid release. The greatest
variation in relative abundance was observed with the cumulated bi-antennary
glycans (m/z 1811). The glycan profiles for the other GlcNAc treatments from the
titration series are presented in the Appendix B.
The structures of native N-glycans from Mgat 5'/_cells grown in low
glucose media are depicted in Figure 38. The native glycans profiles for the
same three GlcNAc treatments as those presented for the Mgat 5+/+ cells are
shown in Figures 39, 40 and 41. The glycan spectra before and after neuraminic
acid release are shown in the upper and lower part of the figures, respectively. In
all spectra the high mannose glycans are marked with a dot.
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, after neuraminic acid release.
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Figure 39 Native N-glycans from Mgat 5'/_ grown in low glucose; A - before neuraminic acid release;
B - after neuraminic acid release.
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The glycan profiles of Mgat 5'1' cells grown in low glucose media showed a
predominant high mannose glycan series similar to Mgat 5+/+cells. However, a
comparison among the eight GlcNAc treatments (profiles of other GlcNAc
treatments are presented in the Appendix B) showed an increasing relative
abundance for the complex glycans in parallel with a decreasing concentration
for the high mannose glycans.

The ratio between complex and high mannose glycans increased in the titration
series and the complex glycans became the predominant peaks in the profile of
Mgat 5'/_cells supplemented with 31 mM GlcNAc (Figure 40). The relative
abundance of N-glycans from the Mgat 5+/+and Mgat 5V'c e lls ’ titration series
were expressed as percents of the total added values and tabulated in Appendix
C. The percent values of different classes of N-linked glycans (bi-antennary, triantennary and high mannose type) were averaged and their ratio variation is
presented in Figures 42 and 43.
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Figure 42. Relative abundance variation for bi-antennary N-glycans
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The ratio between the averaged relative abundances of bi-antennary and
high mannose glycans is represented in Figure 42 as a function of the GlcNAc
concentration in the titration series. The bi-antennary/ high mannose glycan ratio
showed relatively small variations for the Mgat 5+/+titration series and a slight
increase in the cells supplemented with elevated GlcNAc concentrations. In Mgat
5'/_cells the same ratio showed a continuous increase as the GlcNAc
supplements increase. The ratio doubles its value in the cells supplemented with
37.5 mM GlcNAc and then registers a drop for the higher GlcNAc concentrations
(Figure 42).

The relative abundance values for tri-antennary glycans were averaged
and expressed in relation to the averaged high mannose values. This ratio is
plotted in Figure 43 as a function of the GlcNAc concentrations.

c 1.2 i

B M g a t 5 Null
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Figure 43. Relative abundance variation for tri-antennary N-glycans

The tri-antennary/high mannose glycan ratio shows little variation in the Mgat 5+/+
cells. However, the same ratio exhibits a step-wise increase in Mgat 5"/_titration
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series with maximum values for the highest GlcNAc supplement. The elevated
tri-antennary glycan proportions in Mgat 5'/_cells supplemented with 43.75 and
50 mM GlcNAc could explain the decrease of the bi-antennary/high mannose
ratio for the same GlcNAc concentrations (Figure 42). An elevated Golgi
remodeling could generate an increased density of tri-antennary structures to the
detriment of their precursors - the bi-antennary glycans and would suggest a
constant number of occupied glycosylation sites.
The products of GlcNAc transferases increase in concentration along the
Mgat 5'/_cells titration series (m/z 1488,1690,1894). This generates elevated
concentrations of bi-antennary and tri-antennary glycans.
The tetra-antennary glycans were absent from Mgat 5'/_cells, and very low
levels of poly-N-acetyl-lactosaminylated structures were detected. This suggests
the tetra-antennary glycans are preferred for the addition of N-acetyl-lactosamine
extensions. However, the poly-LacNAc structures were either present in trace
amounts or absent from these cells, suggesting that other oligosaccharides may
have rescued the lattice interaction.
A comparison among all eight GlcNAc treatments shows that the relative
abundance of bi-antennary and tri-antennary glycans increases in the cells
supplemented with higher concentration of GlcNAc (m/z 1649, 1853, 2014,
2030). This implies that the surface of Mgat 5'/_cells supplemented with GlcNAc
presents a higher density of bi- and tri-antennary glycans. Although some of
these structures are not mature glycans, they carried at least one Gal-GlcNAc
unit recognized by galectin-3. These analogs are not preferred ligands for
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galectin-3, like poly-LacNAcs, but they appear to interact with this lectin and
participate in lattice formation. I propose that the elevated concentrations of biand tri-antennary sugars may overcome the deficit of Mgat 5 modified glycans
and their poly-LacNAc derivatives and establish cell surface interactions with
adequate avidity to maintain cytokine receptor activation and signal transduction.
To illustrate the variations in concentrations for different glycan types their
relative abundances were summed and expressed as fractions of the total
oligosaccharide pool. The fractions for each glycan category were plotted as a
function of GlcNAc supplement concentration from the Mgat 5"/_titration series
(Figure 44). The graphic shows a decrease in high mannose glycan levels in
parallel with an increase in tri-antennary structures. Although the concentrations
of bi-antennary glycans exhibited variation among different GlcNAc treatments,
overall they were maintained at a steady level. Also a slight increase in
concentration of bisected oligosaccharides could be observed. The spectra and
the graph showed that the most extensive variation in N-linked glycan processing
imposed by the GlcNac supplements was the distortion of the high mannose /
complex glycan ratio and the substantial increase in tri-antennary structures.
The mass spectrometric analysis was used to confirm a computational
simulation of N-glycan processing performed by our collaborators (Figure 45).
The mathematical model takes into consideration the Golgi N-glycan processing,
the distribution of receptor glycoforms and the lattice dependent regulation of
surface receptor.
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The model predicts an increase of tri-antennary structures attached to cytokine
receptors with an increase in GlcNAc concentrations, which correlates with the
experimental mass spectrometry results.
This comparative study shows that cytokine signaling can be modulated
through the interactions established by the cell surface receptor. The receptor
association with the lattice is dependent on genetic influences such as Mgat 5
expression and N-glycan processing by GnT V, which produces high affinity
ligands for galectin-3. Also, cell surface superstructure formation can be
influenced by environmental factors such as high concentrations of available
GlcNAc. This stimulates the hexosamine pathway, which sustains synthesis of
complex type glycans with lower content of N-acetyl-lactosamine (bi- and triantennary glycans) but in higher concentrations. Together, these factors
participate in balancing a regulatory mechanism, which controls discriminatively
activation of morphogenic receptors with ultrasensitive kinetics and of anabolic
receptors in a sensitive, graded manner.
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APPENDIX A

Table 1A. Proposed structures for methylated N-glycans
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APPENDIX B

GlcNAc Titration Series

The spectra presented in this section represent native N-linked glycans
from Mgat 5 cell lines grown in low glucose media supplemented with increasing
GlcNAc concentration. The GlcNAc concentrations in the titration series were: 0
mM, 12.5 mM, 18.75 mM, 25 mM, 31.25 mM, 37.5 mM, 43.75 mM and 50 mM.
All figures in this section show profiles of native N-glycans before
neuraminic acid release in the upper part and after neuraminic acid release in the
lower part.
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Figure 46B. Native N-glycans from Mgat 5+/+ grown in low glucose
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Figure 47B. Native N-glycans from Mgat 5+/+ with 12.5 mM GlcNAc supplement
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Figure 48B. Native N-glycans from Mgat 5+/+ with 18.75 mM GlcNAc supplement
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Figure 49B. Native N-glycans from Mgat 5+/+ with 25 mM GlcNAc supplement
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Figure 50B. Native N-glycans from Mgat 5+/+ with 31.25 mM GlcNAc supplement
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Figure 51B. Native N-glycans from Mgat 5+/+ with 37.5 mM GlcNAc supplement
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Figure 52B. Native N-glycans from Mgat 5+/+ with 43.75 mM GlcNAc supplement
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mM GlcNAc supplement
Figure 53B. Native N-glycans from Mgat 5+/+ with 50
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Figure 54B Native N-glycans from Mgat 57' grown in low glucose
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Figure 55B. Native N-glycans from Mgat 5''' with 12.5 mM GlcNAc supplements
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Figure 56B. Native N-glycans from Mgat 5'/_ with 18.75 mM GlcNAc supplements

oo

Figure 57B. Native N-glycans from Mgat 5_/' with 25 mM GlcNAc supplements
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Figure 58B. Native N-glycans from Mgat 5'/_ with 31 mM GlcNAc supplements
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Figure 59B. Native N-glycans from Mgat 5'/_ with 37.5 mM GlcNAc supplements
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Figure 60B. Native N-glycans from Mgat 5'/_ with 43.75 mM GlcNAc supplements
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Figure 61B. Native N-glycans from Mgat 5'/_ with 50 mM GlcNAc supplements

o>,

APPENDIX C

Relative Abundance Variation of N-glycans in the GlcNAc
Titration Series

The relative abundances of N-linked glycans profiled along the GlcNAc
titration series are tabulated in this section. This values were used for
quantitative estimations.
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